CN101798298B - 咪唑衍生物 - Google Patents
咪唑衍生物 Download PDFInfo
- Publication number
- CN101798298B CN101798298B CN2010101215002A CN201010121500A CN101798298B CN 101798298 B CN101798298 B CN 101798298B CN 2010101215002 A CN2010101215002 A CN 2010101215002A CN 201010121500 A CN201010121500 A CN 201010121500A CN 101798298 B CN101798298 B CN 101798298B
- Authority
- CN
- China
- Prior art keywords
- methyl
- phenyl
- imidazol
- methanol
- imidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title description 2
- 150000002460 imidazoles Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 525
- 238000000034 method Methods 0.000 claims abstract description 215
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 9
- 201000010099 disease Diseases 0.000 claims abstract description 7
- -1 nitro, benzyloxy, hydroxyl Chemical group 0.000 claims description 219
- 238000006243 chemical reaction Methods 0.000 claims description 116
- 229910052739 hydrogen Inorganic materials 0.000 claims description 38
- 239000001257 hydrogen Substances 0.000 claims description 38
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 37
- 239000002253 acid Substances 0.000 claims description 30
- 150000003839 salts Chemical class 0.000 claims description 29
- 150000002431 hydrogen Chemical class 0.000 claims description 20
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 18
- 229910052736 halogen Inorganic materials 0.000 claims description 15
- 150000002367 halogens Chemical class 0.000 claims description 15
- 230000004770 neurodegeneration Effects 0.000 claims description 9
- 208000015122 neurodegenerative disease Diseases 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000003814 drug Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 150000001721 carbon Chemical group 0.000 claims description 7
- 230000001684 chronic effect Effects 0.000 claims description 7
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 claims description 6
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 claims description 6
- 208000002193 Pain Diseases 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 230000001154 acute effect Effects 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 208000000094 Chronic Pain Diseases 0.000 claims description 3
- 208000005298 acute pain Diseases 0.000 claims description 3
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 3
- 230000009385 viral infection Effects 0.000 claims description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 7
- 239000000654 additive Substances 0.000 claims 4
- 230000000996 additive effect Effects 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 2
- 206010008190 Cerebrovascular accident Diseases 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 208000024732 dysthymic disease Diseases 0.000 claims 2
- 125000001072 heteroaryl group Chemical group 0.000 claims 2
- 208000014674 injury Diseases 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- WJJMNDUMQPNECX-UHFFFAOYSA-N dipicolinic acid Chemical compound OC(=O)C1=CC=CC(C(O)=O)=N1 WJJMNDUMQPNECX-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 11
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 abstract description 5
- 230000001537 neural effect Effects 0.000 abstract description 3
- 230000007996 neuronal plasticity Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 726
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 414
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 399
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 364
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 260
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 225
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 221
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 192
- 239000012312 sodium hydride Substances 0.000 description 192
- 229910000104 sodium hydride Inorganic materials 0.000 description 192
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 172
- 238000010626 work up procedure Methods 0.000 description 142
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 134
- 239000012458 free base Substances 0.000 description 127
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 122
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 121
- 239000011541 reaction mixture Substances 0.000 description 111
- 238000004587 chromatography analysis Methods 0.000 description 109
- 239000000126 substance Substances 0.000 description 105
- 239000007787 solid Substances 0.000 description 101
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 101
- 238000011097 chromatography purification Methods 0.000 description 98
- 239000000203 mixture Substances 0.000 description 89
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 85
- 238000002425 crystallisation Methods 0.000 description 77
- 230000008025 crystallization Effects 0.000 description 77
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 76
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 69
- 230000007062 hydrolysis Effects 0.000 description 69
- 238000006460 hydrolysis reaction Methods 0.000 description 69
- 229910052742 iron Inorganic materials 0.000 description 64
- 238000000354 decomposition reaction Methods 0.000 description 61
- FTKASJMIPSSXBP-UHFFFAOYSA-N ethyl 2-nitroacetate Chemical compound CCOC(=O)C[N+]([O-])=O FTKASJMIPSSXBP-UHFFFAOYSA-N 0.000 description 59
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 56
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 55
- 239000000243 solution Substances 0.000 description 55
- PQAMFDRRWURCFQ-UHFFFAOYSA-N 2-ethyl-1h-imidazole Chemical compound CCC1=NC=CN1 PQAMFDRRWURCFQ-UHFFFAOYSA-N 0.000 description 51
- 230000003301 hydrolyzing effect Effects 0.000 description 46
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 44
- 239000000377 silicon dioxide Substances 0.000 description 41
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 39
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 38
- 229910052938 sodium sulfate Inorganic materials 0.000 description 38
- 235000011152 sodium sulphate Nutrition 0.000 description 38
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 36
- 125000000217 alkyl group Chemical group 0.000 description 35
- 239000002178 crystalline material Substances 0.000 description 35
- 239000002904 solvent Substances 0.000 description 35
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 33
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 27
- 239000012074 organic phase Substances 0.000 description 25
- 239000003921 oil Substances 0.000 description 24
- 235000019198 oils Nutrition 0.000 description 24
- 238000010828 elution Methods 0.000 description 21
- 238000001704 evaporation Methods 0.000 description 21
- 230000008020 evaporation Effects 0.000 description 21
- ROERXQQNEPTAMA-UHFFFAOYSA-N 3-bromo-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(Br)=C1 ROERXQQNEPTAMA-UHFFFAOYSA-N 0.000 description 20
- 239000003480 eluent Substances 0.000 description 19
- 238000001914 filtration Methods 0.000 description 18
- 239000000725 suspension Substances 0.000 description 15
- ZYQAQDVNZZIEQW-UHFFFAOYSA-N 4-(chloromethyl)-1-(3,4-dichlorophenyl)imidazole Chemical compound C1=NC(CCl)=CN1C1=CC=C(Cl)C(Cl)=C1 ZYQAQDVNZZIEQW-UHFFFAOYSA-N 0.000 description 14
- 239000012300 argon atmosphere Substances 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 12
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 11
- 239000000284 extract Substances 0.000 description 11
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 11
- 239000012280 lithium aluminium hydride Substances 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 238000010992 reflux Methods 0.000 description 11
- 229920006395 saturated elastomer Polymers 0.000 description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 10
- 239000000908 ammonium hydroxide Substances 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 10
- 125000001424 substituent group Chemical group 0.000 description 10
- 239000012230 colorless oil Substances 0.000 description 9
- 239000006260 foam Substances 0.000 description 9
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- NNGIXGSVAKRJMY-UHFFFAOYSA-N [1-(4-chloro-3-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(Cl)C(C)=CC(N2C=C(CO)N=C2)=C1 NNGIXGSVAKRJMY-UHFFFAOYSA-N 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- CSJLBAMHHLJAAS-UHFFFAOYSA-N diethylaminosulfur trifluoride Chemical compound CCN(CC)S(F)(F)F CSJLBAMHHLJAAS-UHFFFAOYSA-N 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N 4-methylimidazole Chemical compound CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 7
- 239000002480 mineral oil Substances 0.000 description 7
- 235000010446 mineral oil Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- FGQVWDFJJBOQJA-UHFFFAOYSA-N [1-[3-fluoro-5-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC(F)=CC(C(F)(F)F)=C1 FGQVWDFJJBOQJA-UHFFFAOYSA-N 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000003039 volatile agent Substances 0.000 description 6
- JKIGHOARKAIPJI-UHFFFAOYSA-N (3,4-dichlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C(Cl)=C1 JKIGHOARKAIPJI-UHFFFAOYSA-N 0.000 description 5
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- XTULRBGJGPZGJX-UHFFFAOYSA-N [1-(1,3-benzodioxol-5-yl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(OCO2)C2=C1 XTULRBGJGPZGJX-UHFFFAOYSA-N 0.000 description 5
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 5
- 229910000024 caesium carbonate Inorganic materials 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 238000005984 hydrogenation reaction Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- VVIWVQXSOPHAHQ-UHFFFAOYSA-N (1-quinolin-2-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(C=CC=C2)C2=N1 VVIWVQXSOPHAHQ-UHFFFAOYSA-N 0.000 description 4
- JCIJCHSRVPSOML-UHFFFAOYSA-N (4-fluoro-3-methylphenyl)boronic acid Chemical compound CC1=CC(B(O)O)=CC=C1F JCIJCHSRVPSOML-UHFFFAOYSA-N 0.000 description 4
- UWYZHKAOTLEWKK-UHFFFAOYSA-N 1,2,3,4-tetrahydroisoquinoline Chemical compound C1=CC=C2CNCCC2=C1 UWYZHKAOTLEWKK-UHFFFAOYSA-N 0.000 description 4
- GCMNJUJAKQGROZ-UHFFFAOYSA-N 1,2-Dihydroquinolin-2-imine Chemical compound C1=CC=CC2=NC(N)=CC=C21 GCMNJUJAKQGROZ-UHFFFAOYSA-N 0.000 description 4
- FKYKLCCAVXYPJK-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(Cl)C(Cl)=C1 FKYKLCCAVXYPJK-UHFFFAOYSA-N 0.000 description 4
- GWAKORYPOIOXMB-UHFFFAOYSA-N 1-[1-(3,4-dichlorophenyl)imidazol-4-yl]ethanol Chemical compound C1=NC(C(O)C)=CN1C1=CC=C(Cl)C(Cl)=C1 GWAKORYPOIOXMB-UHFFFAOYSA-N 0.000 description 4
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 4
- ZJWJZAJGAHXWAD-UHFFFAOYSA-N 3-(chloromethyl)-5-(3,4-dichlorophenyl)pyridine;hydrochloride Chemical compound Cl.ClCC1=CN=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 ZJWJZAJGAHXWAD-UHFFFAOYSA-N 0.000 description 4
- LZHCUMPFZKOLLM-UHFFFAOYSA-N 4-(chloromethyl)-1-(3,4-dichlorophenyl)pyrazole Chemical compound C1=C(CCl)C=NN1C1=CC=C(Cl)C(Cl)=C1 LZHCUMPFZKOLLM-UHFFFAOYSA-N 0.000 description 4
- CATIRMBZLCOOBF-UHFFFAOYSA-N 5-bromo-1-methyl-2-[(2-methylimidazol-1-yl)methyl]imidazole Chemical compound CC1=NC=CN1CC1=NC=C(Br)N1C CATIRMBZLCOOBF-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- WZWHBHBLGTVFLN-UHFFFAOYSA-N [1-(2,2-difluoro-1,3-benzodioxol-5-yl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(OC(F)(F)O2)C2=C1 WZWHBHBLGTVFLN-UHFFFAOYSA-N 0.000 description 4
- VCBHUUUCZJFSOJ-UHFFFAOYSA-N [1-(2,3-dihydro-1h-inden-5-yl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(CCC2)C2=C1 VCBHUUUCZJFSOJ-UHFFFAOYSA-N 0.000 description 4
- AQLSINLFHZBATF-UHFFFAOYSA-N [1-(3-bromo-4-fluorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(F)C(Br)=C1 AQLSINLFHZBATF-UHFFFAOYSA-N 0.000 description 4
- OIPBQGDCBIAWMA-UHFFFAOYSA-N [1-(3-bromo-5-fluorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC(F)=CC(Br)=C1 OIPBQGDCBIAWMA-UHFFFAOYSA-N 0.000 description 4
- LCZQJUPBICWMNS-UHFFFAOYSA-N [1-(3-chloro-4-fluorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(F)C(Cl)=C1 LCZQJUPBICWMNS-UHFFFAOYSA-N 0.000 description 4
- VPTIUYHHCCKFHA-UHFFFAOYSA-N [1-(3-chloro-4-methoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=C(Cl)C(OC)=CC=C1N1C=C(CO)N=C1 VPTIUYHHCCKFHA-UHFFFAOYSA-N 0.000 description 4
- ZAYPBSPSAPYSGD-UHFFFAOYSA-N [1-(3-chloro-4-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(Cl)C(C)=CC=C1N1C=C(CO)N=C1 ZAYPBSPSAPYSGD-UHFFFAOYSA-N 0.000 description 4
- CCOMFUIKIQUCQB-UHFFFAOYSA-N [1-(3-chlorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(Cl)=C1 CCOMFUIKIQUCQB-UHFFFAOYSA-N 0.000 description 4
- CNOXSCFGRSZZHM-UHFFFAOYSA-N [1-(3-fluoro-4-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(F)C(C)=CC=C1N1C=C(CO)N=C1 CNOXSCFGRSZZHM-UHFFFAOYSA-N 0.000 description 4
- HLVJWYZDGPSROU-UHFFFAOYSA-N [1-(3-methoxy-4-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(C)C(OC)=CC(N2C=C(CO)N=C2)=C1 HLVJWYZDGPSROU-UHFFFAOYSA-N 0.000 description 4
- LJQQNFPUTPYHSG-UHFFFAOYSA-N [1-(3-methoxyphenyl)imidazol-4-yl]methanol Chemical compound COC1=CC=CC(N2C=C(CO)N=C2)=C1 LJQQNFPUTPYHSG-UHFFFAOYSA-N 0.000 description 4
- CEOWUTVJFCMELU-UHFFFAOYSA-N [1-(3-methylsulfanylphenyl)imidazol-4-yl]methanol Chemical compound CSC1=CC=CC(N2C=C(CO)N=C2)=C1 CEOWUTVJFCMELU-UHFFFAOYSA-N 0.000 description 4
- NYEPMTZCBXNNQG-UHFFFAOYSA-N [1-(3-propan-2-ylphenyl)imidazol-4-yl]methanol Chemical compound CC(C)C1=CC=CC(N2C=C(CO)N=C2)=C1 NYEPMTZCBXNNQG-UHFFFAOYSA-N 0.000 description 4
- NRDWMRYAVLJHTB-UHFFFAOYSA-N [1-(3-tert-butylphenyl)imidazol-4-yl]methanol Chemical compound CC(C)(C)C1=CC=CC(N2C=C(CO)N=C2)=C1 NRDWMRYAVLJHTB-UHFFFAOYSA-N 0.000 description 4
- XNLZDUGORXHGMK-UHFFFAOYSA-N [1-(4-bromophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Br)C=C1 XNLZDUGORXHGMK-UHFFFAOYSA-N 0.000 description 4
- NVTUQVVYFMBNKW-UHFFFAOYSA-N [1-(4-chloro-2-fluorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Cl)C=C1F NVTUQVVYFMBNKW-UHFFFAOYSA-N 0.000 description 4
- HQXOBOOLKOVRMM-UHFFFAOYSA-N [1-(4-chloro-3-methoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=C(Cl)C(OC)=CC(N2C=C(CO)N=C2)=C1 HQXOBOOLKOVRMM-UHFFFAOYSA-N 0.000 description 4
- DGWLXHCHHWUICZ-UHFFFAOYSA-N [1-(4-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=CC(C)=CC=C1N1C=C(CO)N=C1 DGWLXHCHHWUICZ-UHFFFAOYSA-N 0.000 description 4
- DLFQRAUSIJIPJF-UHFFFAOYSA-N [1-(4-methylsulfanylphenyl)imidazol-4-yl]methanol Chemical compound C1=CC(SC)=CC=C1N1C=C(CO)N=C1 DLFQRAUSIJIPJF-UHFFFAOYSA-N 0.000 description 4
- LRYBRTVVMNUBOH-UHFFFAOYSA-N [1-(4-phenylmethoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C(C=C1)=CC=C1OCC1=CC=CC=C1 LRYBRTVVMNUBOH-UHFFFAOYSA-N 0.000 description 4
- FCPYMBIOTDEBRN-UHFFFAOYSA-N [1-[3-(1,1-difluoroethyl)-4-fluorophenyl]imidazol-4-yl]methanol Chemical compound C1=C(F)C(C(F)(F)C)=CC(N2C=C(CO)N=C2)=C1 FCPYMBIOTDEBRN-UHFFFAOYSA-N 0.000 description 4
- YLUKVQYWARRBMI-UHFFFAOYSA-N [1-[3-(1,1-difluoroethyl)phenyl]imidazol-4-yl]methanol Chemical compound CC(F)(F)C1=CC=CC(N2C=C(CO)N=C2)=C1 YLUKVQYWARRBMI-UHFFFAOYSA-N 0.000 description 4
- XDEKESQWCXQPAE-UHFFFAOYSA-N [1-[3-(difluoromethoxy)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(OC(F)F)=C1 XDEKESQWCXQPAE-UHFFFAOYSA-N 0.000 description 4
- PBAKZFIOZHFGHJ-UHFFFAOYSA-N [1-[3-(difluoromethyl)-4-fluorophenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(F)C(C(F)F)=C1 PBAKZFIOZHFGHJ-UHFFFAOYSA-N 0.000 description 4
- WIVFZSUWSXFXGK-UHFFFAOYSA-N [1-[3-(difluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(C(F)F)=C1 WIVFZSUWSXFXGK-UHFFFAOYSA-N 0.000 description 4
- VQHBPLNGCQTVFR-UHFFFAOYSA-N [1-[3-(trifluoromethoxy)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(OC(F)(F)F)=C1 VQHBPLNGCQTVFR-UHFFFAOYSA-N 0.000 description 4
- AORJWYNUXVEDBI-UHFFFAOYSA-N [1-[3-(trifluoromethylsulfanyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(SC(F)(F)F)=C1 AORJWYNUXVEDBI-UHFFFAOYSA-N 0.000 description 4
- LTBSJLVWNWNKEO-UHFFFAOYSA-N [1-[3-chloro-4-(trifluoromethoxy)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(OC(F)(F)F)C(Cl)=C1 LTBSJLVWNWNKEO-UHFFFAOYSA-N 0.000 description 4
- PMDDIODMEHCMOS-UHFFFAOYSA-N [1-[3-chloro-4-(trifluoromethylsulfanyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(SC(F)(F)F)C(Cl)=C1 PMDDIODMEHCMOS-UHFFFAOYSA-N 0.000 description 4
- VJACYDGTEVGOFC-UHFFFAOYSA-N [1-[3-fluoro-4-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(C(F)(F)F)C(F)=C1 VJACYDGTEVGOFC-UHFFFAOYSA-N 0.000 description 4
- NKSZVUABIFBEAM-UHFFFAOYSA-N [1-[4-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(C(F)(F)F)C=C1 NKSZVUABIFBEAM-UHFFFAOYSA-N 0.000 description 4
- WXAGIRINLCDGQD-UHFFFAOYSA-N [1-[4-chloro-3-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Cl)C(C(F)(F)F)=C1 WXAGIRINLCDGQD-UHFFFAOYSA-N 0.000 description 4
- CRSCXFIKZAMYMC-UHFFFAOYSA-N [1-[4-methyl-3-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1N1C=C(CO)N=C1 CRSCXFIKZAMYMC-UHFFFAOYSA-N 0.000 description 4
- QCOVPUSEUCVJFP-UHFFFAOYSA-N [4-iodo-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]methanol Chemical compound C[Si](C)(C)CCOCN1C=C(I)N=C1CO QCOVPUSEUCVJFP-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 4
- 229940074439 potassium sodium tartrate Drugs 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- GPEUZDZVAZHJPZ-UHFFFAOYSA-N (1-quinolin-3-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CN=C(C=CC=C2)C2=C1 GPEUZDZVAZHJPZ-UHFFFAOYSA-N 0.000 description 3
- WFHLPYLUELBHDG-UHFFFAOYSA-N (1-quinolin-6-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(N=CC=C2)C2=C1 WFHLPYLUELBHDG-UHFFFAOYSA-N 0.000 description 3
- OUSKDHTWJNYJRN-UHFFFAOYSA-N (1-quinolin-8-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC2=CC=CN=C12 OUSKDHTWJNYJRN-UHFFFAOYSA-N 0.000 description 3
- AIIFDJKPBDONRM-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-methylpyrazole Chemical compound N1=C(C)C=CN1C1=CC=C(Cl)C(Cl)=C1 AIIFDJKPBDONRM-UHFFFAOYSA-N 0.000 description 3
- SOHPBGNXXVHASR-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)imidazole-4-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1N1C=C(C=O)N=C1 SOHPBGNXXVHASR-UHFFFAOYSA-N 0.000 description 3
- ZFMISIAHIVKCQK-UHFFFAOYSA-N 1-(4-fluoro-3-methoxyphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(F)C(OC)=CC(N2C=C(N=C2)C(O)=O)=C1 ZFMISIAHIVKCQK-UHFFFAOYSA-N 0.000 description 3
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 3
- IVNMVIMOKWBLKH-UHFFFAOYSA-N 2-(4-chloro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound C1=C(Cl)C(C)=CC(B2OC(C)(C)C(C)(C)O2)=C1 IVNMVIMOKWBLKH-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- MKBBSFGKFMQPPC-UHFFFAOYSA-N 2-propyl-1h-imidazole Chemical compound CCCC1=NC=CN1 MKBBSFGKFMQPPC-UHFFFAOYSA-N 0.000 description 3
- KPFHVJDYMDWZLX-UHFFFAOYSA-N 3-(1,1-difluoroethyl)-4-fluoroaniline Chemical compound CC(F)(F)C1=CC(N)=CC=C1F KPFHVJDYMDWZLX-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- WSTGOSOTTBCFCR-UHFFFAOYSA-N [1-(1,3-dihydro-2-benzofuran-5-yl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(COC2)C2=C1 WSTGOSOTTBCFCR-UHFFFAOYSA-N 0.000 description 3
- OACLLBLDCGRRAK-UHFFFAOYSA-N [1-(3,4-dichlorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Cl)C(Cl)=C1 OACLLBLDCGRRAK-UHFFFAOYSA-N 0.000 description 3
- PUKDZBHGQRJYCQ-UHFFFAOYSA-N [1-(3,4-dimethylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(C)C(C)=CC=C1N1C=C(CO)N=C1 PUKDZBHGQRJYCQ-UHFFFAOYSA-N 0.000 description 3
- AYSAQPXTWYBVRP-UHFFFAOYSA-N [1-(3-bromophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(Br)=C1 AYSAQPXTWYBVRP-UHFFFAOYSA-N 0.000 description 3
- RJQOWMPNCROWJP-UHFFFAOYSA-N [1-(3-ethenylphenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(C=C)=C1 RJQOWMPNCROWJP-UHFFFAOYSA-N 0.000 description 3
- HWKQFNPBXOVHRZ-UHFFFAOYSA-N [1-(3-ethylphenyl)imidazol-4-yl]methanol Chemical compound CCC1=CC=CC(N2C=C(CO)N=C2)=C1 HWKQFNPBXOVHRZ-UHFFFAOYSA-N 0.000 description 3
- UYLKFSYEKVJLIF-UHFFFAOYSA-N [1-(3-fluoro-4-methoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=C(F)C(OC)=CC=C1N1C=C(CO)N=C1 UYLKFSYEKVJLIF-UHFFFAOYSA-N 0.000 description 3
- WVZNUBYDDXZRDG-UHFFFAOYSA-N [1-(3-methyl-4-propan-2-ylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(C)C(C(C)C)=CC=C1N1C=C(CO)N=C1 WVZNUBYDDXZRDG-UHFFFAOYSA-N 0.000 description 3
- OOZOQKPDAQCJCD-UHFFFAOYSA-N [1-(4-chlorophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Cl)C=C1 OOZOQKPDAQCJCD-UHFFFAOYSA-N 0.000 description 3
- HBSAFNSPZXPQOM-UHFFFAOYSA-N [1-(4-fluoro-3-methylphenyl)imidazol-4-yl]methanol Chemical compound C1=C(F)C(C)=CC(N2C=C(CO)N=C2)=C1 HBSAFNSPZXPQOM-UHFFFAOYSA-N 0.000 description 3
- MJNJDBNKTNCWFN-UHFFFAOYSA-N [1-(4-nitrophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C([N+]([O-])=O)C=C1 MJNJDBNKTNCWFN-UHFFFAOYSA-N 0.000 description 3
- HIJFVWTVGHDENW-UHFFFAOYSA-N [1-(4-phenylphenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(C=2C=CC=CC=2)C=C1 HIJFVWTVGHDENW-UHFFFAOYSA-N 0.000 description 3
- LWHBWUICTXMWOL-UHFFFAOYSA-N [1-(5-chloropyridin-2-yl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(Cl)C=N1 LWHBWUICTXMWOL-UHFFFAOYSA-N 0.000 description 3
- OQTZIVTUYOGTEV-UHFFFAOYSA-N [1-[3-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(C(F)(F)F)=C1 OQTZIVTUYOGTEV-UHFFFAOYSA-N 0.000 description 3
- MRFLORJDMHSJHL-UHFFFAOYSA-N [1-[4-(trifluoromethoxy)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(OC(F)(F)F)C=C1 MRFLORJDMHSJHL-UHFFFAOYSA-N 0.000 description 3
- UZGBFBDWRVBZJT-UHFFFAOYSA-N [1-[4-(trifluoromethylsulfanyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(SC(F)(F)F)C=C1 UZGBFBDWRVBZJT-UHFFFAOYSA-N 0.000 description 3
- PSJWDVYUQSQIBK-UHFFFAOYSA-N [1-[4-fluoro-3-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(F)C(C(F)(F)F)=C1 PSJWDVYUQSQIBK-UHFFFAOYSA-N 0.000 description 3
- KETUIUHTUZUTFH-UHFFFAOYSA-N [1-[4-methoxy-3-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1N1C=C(CO)N=C1 KETUIUHTUZUTFH-UHFFFAOYSA-N 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 3
- 125000000753 cycloalkyl group Chemical group 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- PRYCFQGXJHTEPM-UHFFFAOYSA-N ethyl 1-(3,4-dichlorophenyl)-5-methylimidazole-4-carboxylate Chemical compound CC1=C(C(=O)OCC)N=CN1C1=CC=C(Cl)C(Cl)=C1 PRYCFQGXJHTEPM-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- AIMMZJWTIOWYIZ-UHFFFAOYSA-N (1-isoquinolin-3-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC2=CC=CC=C2C=N1 AIMMZJWTIOWYIZ-UHFFFAOYSA-N 0.000 description 2
- CEPDJFZQAOLOKP-UHFFFAOYSA-N (1-naphthalen-2-ylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC=C(C=CC=C2)C2=C1 CEPDJFZQAOLOKP-UHFFFAOYSA-N 0.000 description 2
- GPEZMQWSEIUCFS-UHFFFAOYSA-N (1-phenylimidazol-4-yl)methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC=C1 GPEZMQWSEIUCFS-UHFFFAOYSA-N 0.000 description 2
- RMGYQBHKEWWTOY-UHFFFAOYSA-N (3,4-difluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(F)=C1 RMGYQBHKEWWTOY-UHFFFAOYSA-N 0.000 description 2
- KXNDYMLJDLCBMV-UHFFFAOYSA-N (5-bromo-1-methylimidazol-2-yl)methanol Chemical compound CN1C(Br)=CN=C1CO KXNDYMLJDLCBMV-UHFFFAOYSA-N 0.000 description 2
- MJUVRTYWUMPBTR-MRXNPFEDSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-n-[1-[(2r)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide Chemical compound FC=1C=C2N(C[C@@H](O)CO)C(C(C)(CO)C)=CC2=CC=1NC(=O)C1(C=2C=C3OC(F)(F)OC3=CC=2)CC1 MJUVRTYWUMPBTR-MRXNPFEDSA-N 0.000 description 2
- DKMFNLSNNGMPON-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-5-yl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(CCC2)C2=C1 DKMFNLSNNGMPON-UHFFFAOYSA-N 0.000 description 2
- BCXOSCQTHVTUET-UHFFFAOYSA-N 1-(2-fluoro-5-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC([N+]([O-])=O)=CC=C1F BCXOSCQTHVTUET-UHFFFAOYSA-N 0.000 description 2
- PUZACGGRUZJBQO-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-4-[(2-methylimidazol-1-yl)methyl]pyrazole Chemical compound CC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)N=C1 PUZACGGRUZJBQO-UHFFFAOYSA-N 0.000 description 2
- QUMOIQBLMRAOCX-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-4-imidazol-1-yl-3-methylpyrazole Chemical compound CC1=NN(C=2C=C(Cl)C(Cl)=CC=2)C=C1N1C=CN=C1 QUMOIQBLMRAOCX-UHFFFAOYSA-N 0.000 description 2
- XFZZPNBSRHMTNT-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-5-methylpyrazole Chemical compound CC1=CC=NN1C1=CC=C(Cl)C(Cl)=C1 XFZZPNBSRHMTNT-UHFFFAOYSA-N 0.000 description 2
- XQCSHEBLGVQAFD-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)imidazole-4-carboxamide Chemical compound C1=NC(C(=O)N)=CN1C1=CC=C(Cl)C(Cl)=C1 XQCSHEBLGVQAFD-UHFFFAOYSA-N 0.000 description 2
- DWUYWFXMMQRVGS-UHFFFAOYSA-N 1-(3,4-dimethylphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(C)C(C)=CC=C1N1C=C(C(O)=O)N=C1 DWUYWFXMMQRVGS-UHFFFAOYSA-N 0.000 description 2
- SDRYSGMVWHIYED-UHFFFAOYSA-N 1-(3-bromophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC(Br)=C1 SDRYSGMVWHIYED-UHFFFAOYSA-N 0.000 description 2
- BLLFLRJMZZPANY-UHFFFAOYSA-N 1-(3-chloro-4-methoxyphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC=C1N1C=C(C(O)=O)N=C1 BLLFLRJMZZPANY-UHFFFAOYSA-N 0.000 description 2
- PYHVRGWTKOZHNU-UHFFFAOYSA-N 1-(3-iodophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC(I)=C1 PYHVRGWTKOZHNU-UHFFFAOYSA-N 0.000 description 2
- JEOVBQLXBQGZSH-UHFFFAOYSA-N 1-(3-methoxyphenyl)imidazole-4-carboxylic acid Chemical compound COC1=CC=CC(N2C=C(N=C2)C(O)=O)=C1 JEOVBQLXBQGZSH-UHFFFAOYSA-N 0.000 description 2
- TUUURTYAHGEXND-UHFFFAOYSA-N 1-(3-methylsulfanylphenyl)imidazole-4-carboxylic acid Chemical compound CSC1=CC=CC(N2C=C(N=C2)C(O)=O)=C1 TUUURTYAHGEXND-UHFFFAOYSA-N 0.000 description 2
- KIPWPZBZDXTUSQ-UHFFFAOYSA-N 1-(3-propan-2-ylphenyl)imidazole-4-carboxylic acid Chemical compound CC(C)C1=CC=CC(N2C=C(N=C2)C(O)=O)=C1 KIPWPZBZDXTUSQ-UHFFFAOYSA-N 0.000 description 2
- BOXLOBBFTWDLPD-UHFFFAOYSA-N 1-(4-bromophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(Br)C=C1 BOXLOBBFTWDLPD-UHFFFAOYSA-N 0.000 description 2
- STDATYKMCLUQSY-UHFFFAOYSA-N 1-(4-chloro-2-fluorophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(Cl)C=C1F STDATYKMCLUQSY-UHFFFAOYSA-N 0.000 description 2
- LDALVFKCZXOZGI-UHFFFAOYSA-N 1-(4-chlorophenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(Cl)C=C1 LDALVFKCZXOZGI-UHFFFAOYSA-N 0.000 description 2
- KFNKFVWGHIQDKX-UHFFFAOYSA-N 1-(4-methoxyphenyl)imidazole-4-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1C=C(C(O)=O)N=C1 KFNKFVWGHIQDKX-UHFFFAOYSA-N 0.000 description 2
- SMRHODLZCBKXFP-UHFFFAOYSA-N 1-(4-methylphenyl)imidazole-4-carboxylic acid Chemical compound C1=CC(C)=CC=C1N1C=C(C(O)=O)N=C1 SMRHODLZCBKXFP-UHFFFAOYSA-N 0.000 description 2
- YROLXBZNWMHUAW-UHFFFAOYSA-N 1-(4-phenylmethoxyphenyl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C(C=C1)=CC=C1OCC1=CC=CC=C1 YROLXBZNWMHUAW-UHFFFAOYSA-N 0.000 description 2
- WTQUHPNXPVOTEN-UHFFFAOYSA-N 1-[3-(difluoromethoxy)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC(OC(F)F)=C1 WTQUHPNXPVOTEN-UHFFFAOYSA-N 0.000 description 2
- HKFDFGAUVIRHMM-UHFFFAOYSA-N 1-[3-(difluoromethyl)-4-fluorophenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(F)C(C(F)F)=C1 HKFDFGAUVIRHMM-UHFFFAOYSA-N 0.000 description 2
- AHWOJVOKELEALV-UHFFFAOYSA-N 1-[3-(trifluoromethoxy)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC(OC(F)(F)F)=C1 AHWOJVOKELEALV-UHFFFAOYSA-N 0.000 description 2
- MAFYTGAURFKOAP-UHFFFAOYSA-N 1-[3-chloro-4-(trifluoromethoxy)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(OC(F)(F)F)C(Cl)=C1 MAFYTGAURFKOAP-UHFFFAOYSA-N 0.000 description 2
- HDTDIQVNBJLHLR-UHFFFAOYSA-N 1-[3-fluoro-5-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC(F)=CC(C(F)(F)F)=C1 HDTDIQVNBJLHLR-UHFFFAOYSA-N 0.000 description 2
- VVGRJILUNQEMCY-UHFFFAOYSA-N 1-[4-(difluoromethoxy)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(OC(F)F)C=C1 VVGRJILUNQEMCY-UHFFFAOYSA-N 0.000 description 2
- NAJSBOXPNXASDA-UHFFFAOYSA-N 1-[4-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(C(F)(F)F)C=C1 NAJSBOXPNXASDA-UHFFFAOYSA-N 0.000 description 2
- IMGHFZMHBCONJK-UHFFFAOYSA-N 1-[4-(trifluoromethylsulfanyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(SC(F)(F)F)C=C1 IMGHFZMHBCONJK-UHFFFAOYSA-N 0.000 description 2
- WESXKHYLBAWMQS-UHFFFAOYSA-N 1-[4-methoxy-3-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=C(C(F)(F)F)C(OC)=CC=C1N1C=C(C(O)=O)N=C1 WESXKHYLBAWMQS-UHFFFAOYSA-N 0.000 description 2
- NGBGDIRFPNRXRV-UHFFFAOYSA-N 1-[4-methyl-3-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=C(C(F)(F)F)C(C)=CC=C1N1C=C(C(O)=O)N=C1 NGBGDIRFPNRXRV-UHFFFAOYSA-N 0.000 description 2
- MWTOUINCOBRHBW-UHFFFAOYSA-N 1-[[1-(1,3-benzodioxol-5-yl)imidazol-4-yl]methyl]-2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1CC1=CN(C=2C=C3OCOC3=CC=2)C=N1 MWTOUINCOBRHBW-UHFFFAOYSA-N 0.000 description 2
- AWQAZKKHWZSGBS-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]imidazol-2-amine Chemical compound NC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 AWQAZKKHWZSGBS-UHFFFAOYSA-N 0.000 description 2
- FTKAQLXBVRNLER-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]imidazole-2-carbaldehyde Chemical compound C1=C(Cl)C(Cl)=CC=C1N1C=C(CN2C(=NC=C2)C=O)N=C1 FTKAQLXBVRNLER-UHFFFAOYSA-N 0.000 description 2
- NCJAJYPBNUFMQK-UHFFFAOYSA-N 1-bromo-3-(1,1-difluoroethyl)benzene Chemical compound CC(F)(F)C1=CC=CC(Br)=C1 NCJAJYPBNUFMQK-UHFFFAOYSA-N 0.000 description 2
- DBYLAWFMMVZTRR-UHFFFAOYSA-N 1-phenylimidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC=C1 DBYLAWFMMVZTRR-UHFFFAOYSA-N 0.000 description 2
- SLHUWMLRDHOSEI-UHFFFAOYSA-N 2-(1,1-difluoroethyl)-1-fluoro-4-nitrobenzene Chemical compound CC(F)(F)C1=CC([N+]([O-])=O)=CC=C1F SLHUWMLRDHOSEI-UHFFFAOYSA-N 0.000 description 2
- OTCOGJNOBVQVOH-UHFFFAOYSA-N 2-(2,3-dihydro-1h-inden-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(CCC2)C2=C1 OTCOGJNOBVQVOH-UHFFFAOYSA-N 0.000 description 2
- UUZLARBBTZODKC-UHFFFAOYSA-N 2-(3-chloro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound C1=C(Cl)C(C)=CC=C1B1OC(C)(C)C(C)(C)O1 UUZLARBBTZODKC-UHFFFAOYSA-N 0.000 description 2
- CSSHEJYXNNBLJD-UHFFFAOYSA-N 2-(chloromethyl)-3-(3,4-dichlorophenyl)pyridine;hydrochloride Chemical compound Cl.ClCC1=NC=CC=C1C1=CC=C(Cl)C(Cl)=C1 CSSHEJYXNNBLJD-UHFFFAOYSA-N 0.000 description 2
- VXIMQWWMIPNFEO-UHFFFAOYSA-N 2-(difluoromethyl)-1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C(C(F)F)=C1 VXIMQWWMIPNFEO-UHFFFAOYSA-N 0.000 description 2
- SUBYSXRGWSURGY-UHFFFAOYSA-N 2-(imidazol-1-ylmethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCN1C=CN=C1 SUBYSXRGWSURGY-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- QWZFWLDICWXMKG-UHFFFAOYSA-N 2-[(4,5-diiodoimidazol-1-yl)methoxy]ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCN1C=NC(I)=C1I QWZFWLDICWXMKG-UHFFFAOYSA-N 0.000 description 2
- JQYPNUVADJAZLP-UHFFFAOYSA-N 2-[1-(3,4-dichlorophenyl)imidazol-4-yl]propan-2-ol Chemical compound C1=NC(C(C)(O)C)=CN1C1=CC=C(Cl)C(Cl)=C1 JQYPNUVADJAZLP-UHFFFAOYSA-N 0.000 description 2
- DSPZNBCXPQKETC-UHFFFAOYSA-N 2-[3-(difluoromethyl)-4-fluorophenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(F)C(C(F)F)=C1 DSPZNBCXPQKETC-UHFFFAOYSA-N 0.000 description 2
- BCRDVCMEIWHGRS-UHFFFAOYSA-N 2-[3-fluoro-5-(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC(F)=CC(C(F)(F)F)=C1 BCRDVCMEIWHGRS-UHFFFAOYSA-N 0.000 description 2
- VBNMWVUQPRYIIM-UHFFFAOYSA-N 2-[4-chloro-3-(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(Cl)C(C(F)(F)F)=C1 VBNMWVUQPRYIIM-UHFFFAOYSA-N 0.000 description 2
- JGMQFPUMJCFTAR-UHFFFAOYSA-N 2-[4-fluoro-3-(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(F)C(C(F)(F)F)=C1 JGMQFPUMJCFTAR-UHFFFAOYSA-N 0.000 description 2
- MBQKTXUCJWIHQQ-UHFFFAOYSA-N 2-cyclopropyl-1h-imidazole Chemical compound C1CC1C1=NC=CN1 MBQKTXUCJWIHQQ-UHFFFAOYSA-N 0.000 description 2
- AOPMQLQOKIUWPQ-UHFFFAOYSA-N 2-nitro-1-[(1-phenylimidazol-4-yl)methyl]imidazole Chemical compound [O-][N+](=O)C1=NC=CN1CC1=CN(C=2C=CC=CC=2)C=N1 AOPMQLQOKIUWPQ-UHFFFAOYSA-N 0.000 description 2
- DOLQYFPDPKPQSS-UHFFFAOYSA-N 3,4-dimethylaniline Chemical compound CC1=CC=C(N)C=C1C DOLQYFPDPKPQSS-UHFFFAOYSA-N 0.000 description 2
- SWJQAZRMWDEZCY-UHFFFAOYSA-N 3-(chloromethyl)-5-(3,4-dimethylphenyl)-2-methylpyridine;hydrochloride Chemical compound Cl.C1=C(C)C(C)=CC=C1C1=CN=C(C)C(CCl)=C1 SWJQAZRMWDEZCY-UHFFFAOYSA-N 0.000 description 2
- VIUDTWATMPPKEL-UHFFFAOYSA-N 3-(trifluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)(F)F)=C1 VIUDTWATMPPKEL-UHFFFAOYSA-N 0.000 description 2
- NLPHAZLCNNDGPS-UHFFFAOYSA-N 3-bromo-5-(chloromethyl)pyridine Chemical compound ClCC1=CN=CC(Br)=C1 NLPHAZLCNNDGPS-UHFFFAOYSA-N 0.000 description 2
- KAWYASGZISVRAL-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1h-benzimidazole Chemical compound C1CCCC2=C1N=CN2 KAWYASGZISVRAL-UHFFFAOYSA-N 0.000 description 2
- YSWBFLWKAIRHEI-UHFFFAOYSA-N 4,5-dimethyl-1h-imidazole Chemical compound CC=1N=CNC=1C YSWBFLWKAIRHEI-UHFFFAOYSA-N 0.000 description 2
- FLSTZMBACVRYQF-UHFFFAOYSA-N 4-(chloromethyl)-1-(4-chloro-3-methylphenyl)imidazole Chemical compound C1=C(Cl)C(C)=CC(N2C=C(CCl)N=C2)=C1 FLSTZMBACVRYQF-UHFFFAOYSA-N 0.000 description 2
- ZLTATSUWHNIWPG-UHFFFAOYSA-N 4-(chloromethyl)-1-(4-chloro-3-methylphenyl)imidazole;hydrochloride Chemical compound Cl.C1=C(Cl)C(C)=CC(N2C=C(CCl)N=C2)=C1 ZLTATSUWHNIWPG-UHFFFAOYSA-N 0.000 description 2
- KMTOVAUSVQAAGF-UHFFFAOYSA-N 4-(chloromethyl)-2-(3,4-dichlorophenyl)pyridine;hydrochloride Chemical compound Cl.ClCC1=CC=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 KMTOVAUSVQAAGF-UHFFFAOYSA-N 0.000 description 2
- JXWQAVVKHPJYIT-UHFFFAOYSA-N 4-(imidazol-1-ylmethyl)-1-(3-methylsulfanylphenyl)imidazole;hydrochloride Chemical compound Cl.CSC1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 JXWQAVVKHPJYIT-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 2
- VRSBHZMIJMLFDU-UHFFFAOYSA-N 4-bromo-2-(1,1-difluoroethyl)-1-fluorobenzene Chemical compound CC(F)(F)C1=CC(Br)=CC=C1F VRSBHZMIJMLFDU-UHFFFAOYSA-N 0.000 description 2
- YHQZVEGLXIBPRA-UHFFFAOYSA-N 4-bromo-2-(difluoromethyl)-1-fluorobenzene Chemical compound FC(F)C1=CC(Br)=CC=C1F YHQZVEGLXIBPRA-UHFFFAOYSA-N 0.000 description 2
- XAACOEWSHBIFGJ-UHFFFAOYSA-N 4-fluoro-3-methoxyaniline Chemical compound COC1=CC(N)=CC=C1F XAACOEWSHBIFGJ-UHFFFAOYSA-N 0.000 description 2
- HXXCJOXVIXQRQL-UHFFFAOYSA-N 4-iodo-1-(2-trimethylsilylethoxymethyl)imidazole-2-carbaldehyde Chemical compound C[Si](C)(C)CCOCN1C=C(I)N=C1C=O HXXCJOXVIXQRQL-UHFFFAOYSA-N 0.000 description 2
- 0 CC(C)*(*(C)C)N Chemical compound CC(C)*(*(C)C)N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GBCZAVOFPOJLED-UHFFFAOYSA-N [1-(3,4-dichlorophenyl)-5-methylimidazol-4-yl]methanol Chemical compound CC1=C(CO)N=CN1C1=CC=C(Cl)C(Cl)=C1 GBCZAVOFPOJLED-UHFFFAOYSA-N 0.000 description 2
- NKPMXZATBKDDKF-UHFFFAOYSA-N [1-(3-cyclopropylphenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(C2CC2)=C1 NKPMXZATBKDDKF-UHFFFAOYSA-N 0.000 description 2
- ZAEBVVPYUMUNSF-UHFFFAOYSA-N [1-(3-iodophenyl)imidazol-4-yl]methanol Chemical compound C1=NC(CO)=CN1C1=CC=CC(I)=C1 ZAEBVVPYUMUNSF-UHFFFAOYSA-N 0.000 description 2
- MXCSJIRXEHAAKH-UHFFFAOYSA-N [1-(4-methoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=CC(OC)=CC=C1N1C=C(CO)N=C1 MXCSJIRXEHAAKH-UHFFFAOYSA-N 0.000 description 2
- JNPNGIBFNIDAKB-UHFFFAOYSA-N [1-[3-methoxy-5-(trifluoromethyl)phenyl]imidazol-4-yl]methanol Chemical compound FC(F)(F)C1=CC(OC)=CC(N2C=C(CO)N=C2)=C1 JNPNGIBFNIDAKB-UHFFFAOYSA-N 0.000 description 2
- QTQVYVVFORFBPE-UHFFFAOYSA-N [2-(3,4-dichlorophenyl)pyridin-4-yl]methanol Chemical compound OCC1=CC=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 QTQVYVVFORFBPE-UHFFFAOYSA-N 0.000 description 2
- BDYVWDMHYNGVGE-UHFFFAOYSA-N [2-(aminomethyl)cyclohexyl]methanamine Chemical compound NCC1CCCCC1CN BDYVWDMHYNGVGE-UHFFFAOYSA-N 0.000 description 2
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 2
- LMPHNPVRJQGOLH-UHFFFAOYSA-N [4-(3,4-dichlorophenyl)pyridin-2-yl]methanol Chemical compound C1=NC(CO)=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 LMPHNPVRJQGOLH-UHFFFAOYSA-N 0.000 description 2
- XDWMNDMWNDSDCX-UHFFFAOYSA-N [5-(3,4-dichlorophenyl)pyridin-3-yl]methanol Chemical compound OCC1=CN=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 XDWMNDMWNDSDCX-UHFFFAOYSA-N 0.000 description 2
- WJAULBCJGQYJGJ-UHFFFAOYSA-N [5-(3,4-dimethylphenyl)-2-methylpyridin-3-yl]methanol;hydrochloride Chemical compound Cl.C1=C(C)C(C)=CC=C1C1=CN=C(C)C(CO)=C1 WJAULBCJGQYJGJ-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- DMVOXQPQNTYEKQ-UHFFFAOYSA-N biphenyl-4-amine Chemical compound C1=CC(N)=CC=C1C1=CC=CC=C1 DMVOXQPQNTYEKQ-UHFFFAOYSA-N 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000021617 central nervous system development Effects 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- DCMCSIQMHXRSOQ-UHFFFAOYSA-N ethyl 1-(5-chloropyridin-2-yl)imidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CC=C(Cl)C=N1 DCMCSIQMHXRSOQ-UHFFFAOYSA-N 0.000 description 2
- VSQJHGXYQNEQSF-UHFFFAOYSA-N ethyl 1-isoquinolin-3-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CC2=CC=CC=C2C=N1 VSQJHGXYQNEQSF-UHFFFAOYSA-N 0.000 description 2
- CDJVFGLANLZYJW-UHFFFAOYSA-N ethyl 1-quinolin-2-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CC=C(C=CC=C2)C2=N1 CDJVFGLANLZYJW-UHFFFAOYSA-N 0.000 description 2
- QWLGMABABAUAEW-UHFFFAOYSA-N ethyl 1-quinolin-3-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CN=C(C=CC=C2)C2=C1 QWLGMABABAUAEW-UHFFFAOYSA-N 0.000 description 2
- FSVNMDBRWBNKQL-UHFFFAOYSA-N ethyl 1-quinolin-6-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CC=C(N=CC=C2)C2=C1 FSVNMDBRWBNKQL-UHFFFAOYSA-N 0.000 description 2
- ZFQHVQVIJRYEOO-UHFFFAOYSA-N ethyl 1-quinolin-8-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OCC)=CN1C1=CC=CC2=CC=CN=C12 ZFQHVQVIJRYEOO-UHFFFAOYSA-N 0.000 description 2
- VEQPMMFEGANTLX-UHFFFAOYSA-N ethyl 3-(3,4-dichlorophenyl)-5-methylimidazole-4-carboxylate Chemical compound CCOC(=O)C1=C(C)N=CN1C1=CC=C(Cl)C(Cl)=C1 VEQPMMFEGANTLX-UHFFFAOYSA-N 0.000 description 2
- AVPJVWVWAJQQQR-UHFFFAOYSA-N ethyl 5-(3,4-dimethylphenyl)-2-methylpyridine-3-carboxylate Chemical compound N1=C(C)C(C(=O)OCC)=CC(C=2C=C(C)C(C)=CC=2)=C1 AVPJVWVWAJQQQR-UHFFFAOYSA-N 0.000 description 2
- KAOPWNFACLSZMA-UHFFFAOYSA-N ethyl acetate nitric acid Chemical compound C(C)OC(C)=O.[N+](=O)(O)[O-] KAOPWNFACLSZMA-UHFFFAOYSA-N 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- KZTDPAXJYUMOQJ-UHFFFAOYSA-N methyl 1-(3,4-dichlorophenyl)imidazole-4-carboxylate Chemical compound C1=NC(C(=O)OC)=CN1C1=CC=C(Cl)C(Cl)=C1 KZTDPAXJYUMOQJ-UHFFFAOYSA-N 0.000 description 2
- CSEWDHCRBWTNPU-UHFFFAOYSA-N methyl 1-naphthalen-2-ylimidazole-4-carboxylate Chemical compound C1=NC(C(=O)OC)=CN1C1=CC=C(C=CC=C2)C2=C1 CSEWDHCRBWTNPU-UHFFFAOYSA-N 0.000 description 2
- UVBDPEYHXBRBJX-UHFFFAOYSA-N methyl 2-(3,4-dichlorophenyl)pyridine-4-carboxylate Chemical compound COC(=O)C1=CC=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 UVBDPEYHXBRBJX-UHFFFAOYSA-N 0.000 description 2
- MLAYIXATNOTYFB-UHFFFAOYSA-N methyl 4-(3,4-dichlorophenyl)pyridine-2-carboxylate Chemical compound C1=NC(C(=O)OC)=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 MLAYIXATNOTYFB-UHFFFAOYSA-N 0.000 description 2
- LNJKNYCNSSODGP-UHFFFAOYSA-N methyl 5-(3,4-dichlorophenyl)pyridine-3-carboxylate Chemical compound COC(=O)C1=CN=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 LNJKNYCNSSODGP-UHFFFAOYSA-N 0.000 description 2
- JKIUOIAWDCRYKK-UHFFFAOYSA-N n-[1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]imidazol-2-yl]acetamide Chemical compound CC(=O)NC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 JKIUOIAWDCRYKK-UHFFFAOYSA-N 0.000 description 2
- VZIVIOINJZXAHR-UHFFFAOYSA-N n-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]ethanethioamide Chemical compound C1=NC(CNC(=S)C)=CN1C1=CC=C(Cl)C(Cl)=C1 VZIVIOINJZXAHR-UHFFFAOYSA-N 0.000 description 2
- GSWAOPJLTADLTN-UHFFFAOYSA-N oxidanimine Chemical compound [O-][NH3+] GSWAOPJLTADLTN-UHFFFAOYSA-N 0.000 description 2
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- WJKHJLXJJJATHN-UHFFFAOYSA-N triflic anhydride Chemical compound FC(F)(F)S(=O)(=O)OS(=O)(=O)C(F)(F)F WJKHJLXJJJATHN-UHFFFAOYSA-N 0.000 description 2
- ORZHAIMGGKHGAG-UHFFFAOYSA-N trimethyl-[2-[[2-[(2-methylimidazol-1-yl)methyl]-4-[3-(trifluoromethyl)phenyl]imidazol-1-yl]methoxy]ethyl]silane Chemical compound CC1=NC=CN1CC1=NC(C=2C=C(C=CC=2)C(F)(F)F)=CN1COCC[Si](C)(C)C ORZHAIMGGKHGAG-UHFFFAOYSA-N 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- CDQDMLWGTVLQEE-UHFFFAOYSA-N (1-methylimidazol-2-yl)methanol Chemical compound CN1C=CN=C1CO CDQDMLWGTVLQEE-UHFFFAOYSA-N 0.000 description 1
- SOCAXRLFGRNEPK-IFZYUDKTSA-N (1r,3s,5r)-2-n-[1-carbamoyl-5-(cyanomethoxy)indol-3-yl]-3-n-[(3-chloro-2-fluorophenyl)methyl]-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide Chemical compound O=C([C@@H]1C[C@H]2C[C@H]2N1C(=O)NC1=CN(C2=CC=C(OCC#N)C=C21)C(=O)N)NCC1=CC=CC(Cl)=C1F SOCAXRLFGRNEPK-IFZYUDKTSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- YMJSQPNVQRHZDW-UHFFFAOYSA-N (3,4-dichlorophenyl)hydrazine Chemical compound NNC1=CC=C(Cl)C(Cl)=C1 YMJSQPNVQRHZDW-UHFFFAOYSA-N 0.000 description 1
- KDVZJKOYSOFXRV-UHFFFAOYSA-N (3,4-dimethylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1C KDVZJKOYSOFXRV-UHFFFAOYSA-N 0.000 description 1
- WJDZZXIDQYKVDG-UHFFFAOYSA-N (3-chloro-4-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(F)C(Cl)=C1 WJDZZXIDQYKVDG-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
- IVUHTLFKBDDICS-UHFFFAOYSA-N (4-methylsulfanylphenyl)boronic acid Chemical compound CSC1=CC=C(B(O)O)C=C1 IVUHTLFKBDDICS-UHFFFAOYSA-N 0.000 description 1
- HGRWHBQLRXWSLV-DEOSSOPVSA-N (4s)-3'-(3,6-dihydro-2h-pyran-5-yl)-1'-fluoro-7'-(3-fluoropyridin-2-yl)spiro[5h-1,3-oxazole-4,5'-chromeno[2,3-c]pyridine]-2-amine Chemical compound C1OC(N)=N[C@]21C1=CC(C=3COCCC=3)=NC(F)=C1OC1=CC=C(C=3C(=CC=CN=3)F)C=C12 HGRWHBQLRXWSLV-DEOSSOPVSA-N 0.000 description 1
- LWMKWJMLIFBMJQ-UHFFFAOYSA-N (5-bromopyridin-1-ium-3-yl)methanol;chloride Chemical compound Cl.OCC1=CN=CC(Br)=C1 LWMKWJMLIFBMJQ-UHFFFAOYSA-N 0.000 description 1
- WDVDHJLKXYCOFS-UHFFFAOYSA-N (5-bromopyridin-3-yl)methanol Chemical compound OCC1=CN=CC(Br)=C1 WDVDHJLKXYCOFS-UHFFFAOYSA-N 0.000 description 1
- JWMSRNHUWSOLLP-WLHGVMLRSA-N (e)-but-2-enedioic acid;[1-(3,4-dichlorophenyl)imidazol-4-yl]methanamine Chemical compound OC(=O)\C=C\C(O)=O.C1=NC(CN)=CN1C1=CC=C(Cl)C(Cl)=C1 JWMSRNHUWSOLLP-WLHGVMLRSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- ACILQFPNTQQMTK-UHFFFAOYSA-N 1-(1,3-benzodioxol-5-yl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(OCO2)C2=C1 ACILQFPNTQQMTK-UHFFFAOYSA-N 0.000 description 1
- NPBTVVHXMVYAHF-UHFFFAOYSA-N 1-(1,3-dihydro-2-benzofuran-5-yl)imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(COC2)C2=C1 NPBTVVHXMVYAHF-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- HAKCBPUULQYIDO-UHFFFAOYSA-N 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.C1=C2OC(F)(F)OC2=CC=C1N(C=1)C=NC=1CN1C=CN=C1 HAKCBPUULQYIDO-UHFFFAOYSA-N 0.000 description 1
- QMATYTFXDIWACW-UHFFFAOYSA-N 1-(2-fluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC=C1F QMATYTFXDIWACW-UHFFFAOYSA-N 0.000 description 1
- AJFWRZUSIQFQKM-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-[(2-methylimidazol-1-yl)methyl]pyrazole Chemical compound CC1=NC=CN1CC1=NN(C=2C=C(Cl)C(Cl)=CC=2)C=C1 AJFWRZUSIQFQKM-UHFFFAOYSA-N 0.000 description 1
- AYYIMJXZLWCCCZ-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)-3-[(2-methylimidazol-1-yl)methyl]pyrazole;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=NN(C=2C=C(Cl)C(Cl)=CC=2)C=C1 AYYIMJXZLWCCCZ-UHFFFAOYSA-N 0.000 description 1
- CORVHHUARAOGDT-UHFFFAOYSA-N 1-(3,4-dichlorophenyl)pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1C1=CC=C(Cl)C(Cl)=C1 CORVHHUARAOGDT-UHFFFAOYSA-N 0.000 description 1
- MAVJRQCJVZZJIY-UHFFFAOYSA-N 1-(3-bromo-4-fluorophenyl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.C1=C(Br)C(F)=CC=C1N1C=C(CN2C=NC=C2)N=C1 MAVJRQCJVZZJIY-UHFFFAOYSA-N 0.000 description 1
- VNGHJBYQRVRUJZ-UHFFFAOYSA-N 1-(3-bromo-5-fluorophenyl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.FC1=CC(Br)=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 VNGHJBYQRVRUJZ-UHFFFAOYSA-N 0.000 description 1
- JYAQYXOVOHJRCS-UHFFFAOYSA-N 1-(3-bromophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(Br)=C1 JYAQYXOVOHJRCS-UHFFFAOYSA-N 0.000 description 1
- ABRCJDSKFMVNQV-UHFFFAOYSA-N 1-(3-chlorophenyl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.ClC1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 ABRCJDSKFMVNQV-UHFFFAOYSA-N 0.000 description 1
- GHJBAWWYRBGBTR-UHFFFAOYSA-N 1-(3-ethylphenyl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.CCC1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 GHJBAWWYRBGBTR-UHFFFAOYSA-N 0.000 description 1
- ICMLJNMYSHLMGF-UHFFFAOYSA-N 1-(3-fluoro-4-methylphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(F)C(C)=CC=C1N1C=C(C(O)=O)N=C1 ICMLJNMYSHLMGF-UHFFFAOYSA-N 0.000 description 1
- ONBLIMGPEDBQDF-UHFFFAOYSA-N 1-(3-methoxy-4-methylphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(C)C(OC)=CC(N2C=C(N=C2)C(O)=O)=C1 ONBLIMGPEDBQDF-UHFFFAOYSA-N 0.000 description 1
- KBXHYRPEPNXKBI-UHFFFAOYSA-N 1-(3-tert-butylphenyl)-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.CC(C)(C)C1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 KBXHYRPEPNXKBI-UHFFFAOYSA-N 0.000 description 1
- ITYOJCYHHPEWRM-UHFFFAOYSA-N 1-(4-chloro-3-methoxyphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(Cl)C(OC)=CC(N2C=C(N=C2)C(O)=O)=C1 ITYOJCYHHPEWRM-UHFFFAOYSA-N 0.000 description 1
- CIMCKPOLRXWABV-UHFFFAOYSA-N 1-(4-chloro-3-methylphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(N2C=C(N=C2)C(O)=O)=C1 CIMCKPOLRXWABV-UHFFFAOYSA-N 0.000 description 1
- HWTRGBLMLITTIF-UHFFFAOYSA-N 1-(4-fluoro-3-methylphenyl)imidazole-4-carboxylic acid Chemical compound C1=C(F)C(C)=CC(N2C=C(N=C2)C(O)=O)=C1 HWTRGBLMLITTIF-UHFFFAOYSA-N 0.000 description 1
- UJFWIFJARQEILB-UHFFFAOYSA-N 1-(4-methylsulfanylphenyl)imidazole-4-carboxylic acid Chemical compound C1=CC(SC)=CC=C1N1C=C(C(O)=O)N=C1 UJFWIFJARQEILB-UHFFFAOYSA-N 0.000 description 1
- GXTDOTQNTNYACB-UHFFFAOYSA-N 1-[3-(1,1-difluoroethyl)-4-fluorophenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.C1=C(F)C(C(F)(F)C)=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 GXTDOTQNTNYACB-UHFFFAOYSA-N 0.000 description 1
- QFOUZOWTVFISHR-UHFFFAOYSA-N 1-[3-(1,1-difluoroethyl)phenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.CC(F)(F)C1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 QFOUZOWTVFISHR-UHFFFAOYSA-N 0.000 description 1
- LIGQTBZOHIVOTR-UHFFFAOYSA-N 1-[3-(difluoromethoxy)phenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.FC(F)OC1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 LIGQTBZOHIVOTR-UHFFFAOYSA-N 0.000 description 1
- KVAUHOLFAJAZOT-UHFFFAOYSA-N 1-[3-(difluoromethyl)-4-fluorophenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.C1=C(F)C(C(F)F)=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 KVAUHOLFAJAZOT-UHFFFAOYSA-N 0.000 description 1
- WEUXDILLFYNKLO-UHFFFAOYSA-N 1-[3-(difluoromethyl)-4-fluorophenyl]-4-[(2-ethylimidazol-1-yl)methyl]imidazole hydrochloride Chemical compound Cl.FC(C=1C=C(C=CC1F)N1C=NC(=C1)CN1C(=NC=C1)CC)F WEUXDILLFYNKLO-UHFFFAOYSA-N 0.000 description 1
- XOSNCWSACUOULT-UHFFFAOYSA-N 1-[3-(difluoromethyl)phenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.FC(F)C1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 XOSNCWSACUOULT-UHFFFAOYSA-N 0.000 description 1
- RXJBJMWBDZSPJW-UHFFFAOYSA-N 1-[3-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=CC(C(F)(F)F)=C1 RXJBJMWBDZSPJW-UHFFFAOYSA-N 0.000 description 1
- FJWDICOBDZNPQR-UHFFFAOYSA-N 1-[3-chloro-4-(trifluoromethylsulfanyl)phenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.C1=C(Cl)C(SC(F)(F)F)=CC=C1N1C=C(CN2C=NC=C2)N=C1 FJWDICOBDZNPQR-UHFFFAOYSA-N 0.000 description 1
- VJHWAQCBXOVKGG-UHFFFAOYSA-N 1-[3-fluoro-4-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(C(F)(F)F)C(F)=C1 VJHWAQCBXOVKGG-UHFFFAOYSA-N 0.000 description 1
- ANJXQPWGVJUXRV-UHFFFAOYSA-N 1-[3-fluoro-5-(trifluoromethyl)phenyl]-4-(imidazol-1-ylmethyl)imidazole;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(F)=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 ANJXQPWGVJUXRV-UHFFFAOYSA-N 0.000 description 1
- FFVAZGMFLLEYQH-UHFFFAOYSA-N 1-[4-fluoro-3-(trifluoromethyl)phenyl]imidazole-4-carboxylic acid Chemical compound C1=NC(C(=O)O)=CN1C1=CC=C(F)C(C(F)(F)F)=C1 FFVAZGMFLLEYQH-UHFFFAOYSA-N 0.000 description 1
- DREICKUWUMDPHQ-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]-4,5,6,7-tetrahydrobenzimidazole Chemical compound C1=C(Cl)C(Cl)=CC=C1N1C=C(CN2C=3CCCCC=3N=C2)N=C1 DREICKUWUMDPHQ-UHFFFAOYSA-N 0.000 description 1
- FTDDLVLMAJBZLQ-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]-n-ethylimidazol-2-amine;hydrochloride Chemical compound Cl.CCNC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 FTDDLVLMAJBZLQ-UHFFFAOYSA-N 0.000 description 1
- SMTZMHWALXWDPR-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]-n-methylimidazol-2-amine Chemical compound CNC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 SMTZMHWALXWDPR-UHFFFAOYSA-N 0.000 description 1
- HARGETLUADHYJS-UHFFFAOYSA-N 1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]-n-methylimidazol-2-amine;hydrochloride Chemical compound Cl.CNC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 HARGETLUADHYJS-UHFFFAOYSA-N 0.000 description 1
- YYOLUFPDFLPMCS-UHFFFAOYSA-N 1-[[1-(4-chloro-3-methylphenyl)imidazol-4-yl]methyl]-4,5,6,7-tetrahydrobenzimidazole Chemical compound C1=C(Cl)C(C)=CC(N2C=C(CN3C=4CCCCC=4N=C3)N=C2)=C1 YYOLUFPDFLPMCS-UHFFFAOYSA-N 0.000 description 1
- CCPINXHORPBKPE-UHFFFAOYSA-N 1-[[1-(4-chloro-3-methylphenyl)imidazol-4-yl]methyl]imidazol-2-amine Chemical compound C1=C(Cl)C(C)=CC(N2C=C(CN3C(=NC=C3)N)N=C2)=C1 CCPINXHORPBKPE-UHFFFAOYSA-N 0.000 description 1
- CZXXZRIHUHYXIQ-UHFFFAOYSA-N 1-bromo-2,3,4,6-tetrafluoro-5-methylbenzene Chemical compound CC1=C(F)C(F)=C(F)C(Br)=C1F CZXXZRIHUHYXIQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- NKWCGTOZTHZDHB-UHFFFAOYSA-N 1h-imidazol-1-ium-4-carboxylate Chemical compound OC(=O)C1=CNC=N1 NKWCGTOZTHZDHB-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- CVYQRDKVWVBOFP-UHFFFAOYSA-N 2,2-difluoro-1,3-benzodioxol-5-amine Chemical compound NC1=CC=C2OC(F)(F)OC2=C1 CVYQRDKVWVBOFP-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- NKUBICRAUVMYKQ-UHFFFAOYSA-N 2,3-dihydro-1h-inden-5-yl trifluoromethanesulfonate Chemical compound FC(F)(F)S(=O)(=O)OC1=CC=C2CCCC2=C1 NKUBICRAUVMYKQ-UHFFFAOYSA-N 0.000 description 1
- RWJUUXWJBMIGKA-UHFFFAOYSA-N 2-(2,3-dihydro-1-benzofuran-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=C(OCC2)C2=C1 RWJUUXWJBMIGKA-UHFFFAOYSA-N 0.000 description 1
- WWLNOHNILZUXSW-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-4-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CC=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 WWLNOHNILZUXSW-UHFFFAOYSA-N 0.000 description 1
- LZJFUVJJIUXGEF-UHFFFAOYSA-N 2-(3,4-dichlorophenyl)-4-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CC=NC(C=2C=C(Cl)C(Cl)=CC=2)=C1 LZJFUVJJIUXGEF-UHFFFAOYSA-N 0.000 description 1
- OTTPBKINJOYJGW-UHFFFAOYSA-N 2-(3,4-dimethylphenyl)acetic acid Chemical compound CC1=CC=C(CC(O)=O)C=C1C OTTPBKINJOYJGW-UHFFFAOYSA-N 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical class CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- OGICWSRSLAYNBM-UHFFFAOYSA-N 2-[3-(1,1-difluoroethyl)-4-fluorophenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound C1=C(F)C(C(F)(F)C)=CC(B2OC(C)(C)C(C)(C)O2)=C1 OGICWSRSLAYNBM-UHFFFAOYSA-N 0.000 description 1
- SAOHVIRSMBJWCW-UHFFFAOYSA-N 2-[4-(imidazol-1-ylmethyl)imidazol-1-yl]quinoline Chemical compound C=1N(C=2N=C3C=CC=CC3=CC=2)C=NC=1CN1C=CN=C1 SAOHVIRSMBJWCW-UHFFFAOYSA-N 0.000 description 1
- HYFFBAOBAREIBM-UHFFFAOYSA-N 2-[4-[(2-ethylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CCC1=NC=CN1CC1=CN(C=2N=C3C=CC=CC3=CC=2)C=N1 HYFFBAOBAREIBM-UHFFFAOYSA-N 0.000 description 1
- SKKRRNZAPYFEBX-UHFFFAOYSA-N 2-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CC1=NC=CN1CC1=CN(C=2N=C3C=CC=CC3=CC=2)C=N1 SKKRRNZAPYFEBX-UHFFFAOYSA-N 0.000 description 1
- UTIOJHIJPUWABN-UHFFFAOYSA-N 2-[5-[(2-methylimidazol-1-yl)methyl]pyridin-3-yl]-3,4-dihydro-1h-isoquinoline;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(N2CC3=CC=CC=C3CC2)=C1 UTIOJHIJPUWABN-UHFFFAOYSA-N 0.000 description 1
- SCVJRXQHFJXZFZ-KVQBGUIXSA-N 2-amino-9-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3h-purine-6-thione Chemical compound C1=2NC(N)=NC(=S)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)O1 SCVJRXQHFJXZFZ-KVQBGUIXSA-N 0.000 description 1
- AKPSDNSGJJZALO-UHFFFAOYSA-N 2-benzofuran-1-amine Chemical compound C1=CC=CC2=C(N)OC=C21 AKPSDNSGJJZALO-UHFFFAOYSA-N 0.000 description 1
- HTFXWAOSQODIBI-UHFFFAOYSA-N 2-benzyl-1,3-dihydropyrrolo[3,4-c]pyridine Chemical compound C1C2=CC=NC=C2CN1CC1=CC=CC=C1 HTFXWAOSQODIBI-UHFFFAOYSA-N 0.000 description 1
- PJYASWQMTNNSSL-UHFFFAOYSA-N 2-chloro-4-iodo-1-methylbenzene Chemical compound CC1=CC=C(I)C=C1Cl PJYASWQMTNNSSL-UHFFFAOYSA-N 0.000 description 1
- QXCOHSRHFCHCHN-UHFFFAOYSA-N 2-chloropyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(Cl)=C1 QXCOHSRHFCHCHN-UHFFFAOYSA-N 0.000 description 1
- VVXFDFQEIRGULC-UHFFFAOYSA-N 2-fluoro-5-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(F)C(C=O)=C1 VVXFDFQEIRGULC-UHFFFAOYSA-N 0.000 description 1
- FALCXGCLOUKBSP-UHFFFAOYSA-N 2-iodopyridine-4-carboxylic acid Chemical compound OC(=O)C1=CC=NC(I)=C1 FALCXGCLOUKBSP-UHFFFAOYSA-N 0.000 description 1
- LXBGSDVWAMZHDD-UHFFFAOYSA-O 2-methyl-1h-imidazol-3-ium Chemical compound CC=1NC=C[NH+]=1 LXBGSDVWAMZHDD-UHFFFAOYSA-O 0.000 description 1
- SVOCLWUDDWXHFW-UHFFFAOYSA-N 2-methylsulfanyl-1h-imidazole Chemical compound CSC1=NC=CN1 SVOCLWUDDWXHFW-UHFFFAOYSA-N 0.000 description 1
- ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
- FUOZJYASZOSONT-UHFFFAOYSA-N 2-propan-2-yl-1h-imidazole Chemical compound CC(C)C1=NC=CN1 FUOZJYASZOSONT-UHFFFAOYSA-N 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- SDYWXFYBZPNOFX-UHFFFAOYSA-N 3,4-dichloroaniline Chemical compound NC1=CC=C(Cl)C(Cl)=C1 SDYWXFYBZPNOFX-UHFFFAOYSA-N 0.000 description 1
- QDGJIBRTFXRYTH-UHFFFAOYSA-N 3-(1,1-difluoroethyl)aniline Chemical compound CC(F)(F)C1=CC=CC(N)=C1 QDGJIBRTFXRYTH-UHFFFAOYSA-N 0.000 description 1
- ZIKBQUZHEGEQIH-UHFFFAOYSA-N 3-(2,3-dihydro-1h-inden-5-yl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C3CCCC3=CC=2)=C1 ZIKBQUZHEGEQIH-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- LRABWWHVIYKVCS-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-5-[(2-ethylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CCC1=NC=CN1CC1=CN=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 LRABWWHVIYKVCS-UHFFFAOYSA-N 0.000 description 1
- NPZIRCRKMPGIJG-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(Cl)C(Cl)=CC=2)=C1 NPZIRCRKMPGIJG-UHFFFAOYSA-N 0.000 description 1
- KAWNKINRZKUWNO-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-5-imidazol-1-yl-2-methylpyridine;hydrochloride Chemical compound Cl.CC1=NC=C(N2C=NC=C2)C=C1C1=CC=C(Cl)C(Cl)=C1 KAWNKINRZKUWNO-UHFFFAOYSA-N 0.000 description 1
- LNTGZUOQTFPUPE-UHFFFAOYSA-N 3-(3,4-difluorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(F)C(F)=CC=2)=C1 LNTGZUOQTFPUPE-UHFFFAOYSA-N 0.000 description 1
- SJBJJLMAIRXOTJ-UHFFFAOYSA-N 3-(3,4-dimethylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(C)=CC=2)=C1 SJBJJLMAIRXOTJ-UHFFFAOYSA-N 0.000 description 1
- FQTRXHCAIKDGEZ-UHFFFAOYSA-N 3-(3,4-dimethylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(C)=CC=2)=C1 FQTRXHCAIKDGEZ-UHFFFAOYSA-N 0.000 description 1
- HZFKNZVXVQVYMK-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(Cl)C(F)=CC=2)=C1 HZFKNZVXVQVYMK-UHFFFAOYSA-N 0.000 description 1
- VCZZCSAYJIUZQJ-UHFFFAOYSA-N 3-(3-chloro-4-fluorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(Cl)C(F)=CC=2)=C1 VCZZCSAYJIUZQJ-UHFFFAOYSA-N 0.000 description 1
- ZOQWJUBTOLDUFM-UHFFFAOYSA-N 3-(3-chloro-4-methylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(Cl)C(C)=CC=2)=C1 ZOQWJUBTOLDUFM-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WPINCYFUGZDAJF-UHFFFAOYSA-N 3-(4-chloro-3-methylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(Cl)=CC=2)=C1 WPINCYFUGZDAJF-UHFFFAOYSA-N 0.000 description 1
- RLMVOMPMWBHIHF-UHFFFAOYSA-N 3-(4-chloro-3-methylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(Cl)=CC=2)=C1 RLMVOMPMWBHIHF-UHFFFAOYSA-N 0.000 description 1
- BFHKYZYHDBPJNX-UHFFFAOYSA-N 3-(4-chlorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=CC(Cl)=CC=2)=C1 BFHKYZYHDBPJNX-UHFFFAOYSA-N 0.000 description 1
- RASQRGFTCCTZCY-UHFFFAOYSA-N 3-(4-fluoro-3-methylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(F)=CC=2)=C1 RASQRGFTCCTZCY-UHFFFAOYSA-N 0.000 description 1
- MXNQUWYNQJLSSC-UHFFFAOYSA-N 3-(4-fluoro-3-methylphenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C)C(F)=CC=2)=C1 MXNQUWYNQJLSSC-UHFFFAOYSA-N 0.000 description 1
- PNTXIKPOQUOSHH-UHFFFAOYSA-N 3-(4-fluorophenyl)-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=CC(F)=CC=2)=C1 PNTXIKPOQUOSHH-UHFFFAOYSA-N 0.000 description 1
- RSOFZRXRIPVBBM-UHFFFAOYSA-N 3-(difluoromethoxy)aniline Chemical compound NC1=CC=CC(OC(F)F)=C1 RSOFZRXRIPVBBM-UHFFFAOYSA-N 0.000 description 1
- IFWSBTBYKXRINT-UHFFFAOYSA-N 3-(difluoromethyl)-4-fluoroaniline Chemical compound NC1=CC=C(F)C(C(F)F)=C1 IFWSBTBYKXRINT-UHFFFAOYSA-N 0.000 description 1
- YHMBBGQPJORBDM-UHFFFAOYSA-N 3-(difluoromethyl)-4-fluoroaniline;hydrochloride Chemical compound Cl.NC1=CC=C(F)C(C(F)F)=C1 YHMBBGQPJORBDM-UHFFFAOYSA-N 0.000 description 1
- IDFPXKDJNDYDKA-UHFFFAOYSA-N 3-(difluoromethyl)aniline Chemical compound NC1=CC=CC(C(F)F)=C1 IDFPXKDJNDYDKA-UHFFFAOYSA-N 0.000 description 1
- SADHVOSOZBAAGL-UHFFFAOYSA-N 3-(trifluoromethoxy)aniline Chemical compound NC1=CC=CC(OC(F)(F)F)=C1 SADHVOSOZBAAGL-UHFFFAOYSA-N 0.000 description 1
- DENPAKQJZNDKEL-UHFFFAOYSA-N 3-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=CC(SC(F)(F)F)=C1 DENPAKQJZNDKEL-UHFFFAOYSA-N 0.000 description 1
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 description 1
- YYIJENMDEWCKGO-UHFFFAOYSA-N 3-[(2-methylimidazol-1-yl)methyl]-5-[3-(trifluoromethyl)phenyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C=CC=2)C(F)(F)F)=C1 YYIJENMDEWCKGO-UHFFFAOYSA-N 0.000 description 1
- MFCAJPXIFKOZTG-UHFFFAOYSA-N 3-[(2-methylimidazol-1-yl)methyl]-5-[4-(trifluoromethyl)phenyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=CC(=CC=2)C(F)(F)F)=C1 MFCAJPXIFKOZTG-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- IRTBJFWHSJUINH-UHFFFAOYSA-N 3-[3-(1,1-difluoroethyl)-4-fluorophenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C(F)=CC=2)C(C)(F)F)=C1 IRTBJFWHSJUINH-UHFFFAOYSA-N 0.000 description 1
- FWMHOBNHKZPLFL-UHFFFAOYSA-N 3-[3-(1,1-difluoroethyl)phenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C=CC=2)C(C)(F)F)=C1 FWMHOBNHKZPLFL-UHFFFAOYSA-N 0.000 description 1
- NYFIPHFWOJBCHC-UHFFFAOYSA-N 3-[3-(difluoromethyl)-4-fluorophenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C(F)=CC=2)C(F)F)=C1 NYFIPHFWOJBCHC-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- XNQHFCYQNXNGFT-UHFFFAOYSA-N 3-[3-fluoro-5-(trifluoromethyl)phenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C=C(F)C=2)C(F)(F)F)=C1 XNQHFCYQNXNGFT-UHFFFAOYSA-N 0.000 description 1
- IWNDACNBCYNZIX-UHFFFAOYSA-N 3-[4-[(2-ethylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CCC1=NC=CN1CC1=CN(C=2C=C3C=CC=CC3=NC=2)C=N1 IWNDACNBCYNZIX-UHFFFAOYSA-N 0.000 description 1
- GDRNHQSVSRXRFO-UHFFFAOYSA-N 3-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]isoquinoline;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN(C=2N=CC3=CC=CC=C3C=2)C=N1 GDRNHQSVSRXRFO-UHFFFAOYSA-N 0.000 description 1
- LFMDXVVKZLDZCB-UHFFFAOYSA-N 3-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CC1=NC=CN1CC1=CN(C=2C=C3C=CC=CC3=NC=2)C=N1 LFMDXVVKZLDZCB-UHFFFAOYSA-N 0.000 description 1
- JEAGWXFPBOBGEN-UHFFFAOYSA-N 3-[4-chloro-3-(trifluoromethyl)phenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CN=CC(C=2C=C(C(Cl)=CC=2)C(F)(F)F)=C1 JEAGWXFPBOBGEN-UHFFFAOYSA-N 0.000 description 1
- IXJKOEORMRYQDM-UHFFFAOYSA-N 3-[4-chloro-3-(trifluoromethyl)phenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C(Cl)=CC=2)C(F)(F)F)=C1 IXJKOEORMRYQDM-UHFFFAOYSA-N 0.000 description 1
- BYRGZHSUMQTBIC-UHFFFAOYSA-N 3-[4-fluoro-3-(trifluoromethyl)phenyl]-5-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CN=CC(C=2C=C(C(F)=CC=2)C(F)(F)F)=C1 BYRGZHSUMQTBIC-UHFFFAOYSA-N 0.000 description 1
- KOWPUNQBGWIERF-UHFFFAOYSA-N 3-bromo-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Br)=C1 KOWPUNQBGWIERF-UHFFFAOYSA-N 0.000 description 1
- NGZAVSDIXFIWHJ-UHFFFAOYSA-N 3-bromo-5-fluoroaniline Chemical compound NC1=CC(F)=CC(Br)=C1 NGZAVSDIXFIWHJ-UHFFFAOYSA-N 0.000 description 1
- DHYHYLGCQVVLOQ-UHFFFAOYSA-N 3-bromoaniline Chemical compound NC1=CC=CC(Br)=C1 DHYHYLGCQVVLOQ-UHFFFAOYSA-N 0.000 description 1
- BLOPJEJSRKMVSU-UHFFFAOYSA-N 3-chloro-4-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=C(SC(F)(F)F)C(Cl)=C1 BLOPJEJSRKMVSU-UHFFFAOYSA-N 0.000 description 1
- YSEMCVGMNUUNRK-UHFFFAOYSA-N 3-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Cl)=C1 YSEMCVGMNUUNRK-UHFFFAOYSA-N 0.000 description 1
- LGCOAKFQLUXQAB-UHFFFAOYSA-N 3-chloro-5-(trifluoromethoxy)aniline Chemical compound NC1=CC(Cl)=CC(OC(F)(F)F)=C1 LGCOAKFQLUXQAB-UHFFFAOYSA-N 0.000 description 1
- RQKFYFNZSHWXAW-UHFFFAOYSA-N 3-chloro-p-toluidine Chemical compound CC1=CC=C(N)C=C1Cl RQKFYFNZSHWXAW-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- WQKQODZOQAFYPR-UHFFFAOYSA-N 3-fluoro-5-(trifluoromethyl)aniline Chemical compound NC1=CC(F)=CC(C(F)(F)F)=C1 WQKQODZOQAFYPR-UHFFFAOYSA-N 0.000 description 1
- FFCSRWGYGMRBGD-UHFFFAOYSA-N 3-iodoaniline Chemical compound NC1=CC=CC(I)=C1 FFCSRWGYGMRBGD-UHFFFAOYSA-N 0.000 description 1
- ONADZNBSLRAJFW-UHFFFAOYSA-N 3-methoxy-4-methylaniline Chemical compound COC1=CC(N)=CC=C1C ONADZNBSLRAJFW-UHFFFAOYSA-N 0.000 description 1
- VTFGJEYZCUWSAM-UHFFFAOYSA-N 3-methoxy-5-(trifluoromethyl)aniline Chemical compound COC1=CC(N)=CC(C(F)(F)F)=C1 VTFGJEYZCUWSAM-UHFFFAOYSA-N 0.000 description 1
- MKYJJJUJQHKWNM-UHFFFAOYSA-N 3-methyl-4-propan-2-ylaniline Chemical compound CC(C)C1=CC=C(N)C=C1C MKYJJJUJQHKWNM-UHFFFAOYSA-N 0.000 description 1
- KCHLDNLIJVSRPK-UHFFFAOYSA-N 3-methylsulfanylaniline Chemical compound CSC1=CC=CC(N)=C1 KCHLDNLIJVSRPK-UHFFFAOYSA-N 0.000 description 1
- XCCNRBCNYGWTQX-UHFFFAOYSA-N 3-propan-2-ylaniline Chemical compound CC(C)C1=CC=CC(N)=C1 XCCNRBCNYGWTQX-UHFFFAOYSA-N 0.000 description 1
- DPKTVUKEPNBABS-UHFFFAOYSA-N 3-tert-butylaniline Chemical compound CC(C)(C)C1=CC=CC(N)=C1 DPKTVUKEPNBABS-UHFFFAOYSA-N 0.000 description 1
- PJCCSZUMZMCWSX-UHFFFAOYSA-N 4,4-Dimethoxy-2-butanone Chemical compound COC(OC)CC(C)=O PJCCSZUMZMCWSX-UHFFFAOYSA-N 0.000 description 1
- XMWPTVMTXKJONE-UHFFFAOYSA-N 4,5-diiodo-1h-imidazole Chemical compound IC=1N=CNC=1I XMWPTVMTXKJONE-UHFFFAOYSA-N 0.000 description 1
- NCTMEOZLIBUPHN-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-[(2-methylimidazol-1-yl)methyl]pyridine Chemical compound CC1=NC=CN1CC1=CC(C=2C=C(Cl)C(Cl)=CC=2)=CC=N1 NCTMEOZLIBUPHN-UHFFFAOYSA-N 0.000 description 1
- JYKNBMVGTHFWNU-UHFFFAOYSA-N 4-(3,4-dichlorophenyl)-2-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CC(C=2C=C(Cl)C(Cl)=CC=2)=CC=N1 JYKNBMVGTHFWNU-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- YYFIUGGMDACGMK-UHFFFAOYSA-N 4-(chloromethyl)-1-(3,4-dichlorophenyl)-3-methyl-2h-imidazole Chemical compound C1=C(CCl)N(C)CN1C1=CC=C(Cl)C(Cl)=C1 YYFIUGGMDACGMK-UHFFFAOYSA-N 0.000 description 1
- OPJCTTOCIFCYEZ-UHFFFAOYSA-N 4-(imidazol-1-ylmethyl)-1-(3-propan-2-ylphenyl)imidazole;hydrochloride Chemical compound Cl.CC(C)C1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 OPJCTTOCIFCYEZ-UHFFFAOYSA-N 0.000 description 1
- UDXYBYPWBGSBEF-UHFFFAOYSA-N 4-(imidazol-1-ylmethyl)-1-[3-(trifluoromethoxy)phenyl]imidazole;hydrochloride Chemical compound Cl.FC(F)(F)OC1=CC=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 UDXYBYPWBGSBEF-UHFFFAOYSA-N 0.000 description 1
- JUISVUYMGWTXDQ-UHFFFAOYSA-N 4-(imidazol-1-ylmethyl)-1-[3-methoxy-5-(trifluoromethyl)phenyl]imidazole;hydrochloride Chemical compound Cl.FC(F)(F)C1=CC(OC)=CC(N2C=C(CN3C=NC=C3)N=C2)=C1 JUISVUYMGWTXDQ-UHFFFAOYSA-N 0.000 description 1
- XUJFOSLZQITUOI-UHFFFAOYSA-N 4-(trifluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)(F)F)C=C1 XUJFOSLZQITUOI-UHFFFAOYSA-N 0.000 description 1
- OHHHTUXVBNGOGI-UHFFFAOYSA-N 4-(trifluoromethylsulfanyl)aniline Chemical compound NC1=CC=C(SC(F)(F)F)C=C1 OHHHTUXVBNGOGI-UHFFFAOYSA-N 0.000 description 1
- LNKBDFVSILQKSI-UHFFFAOYSA-N 4-Chloro-3-methoxyaniline Chemical compound COC1=CC(N)=CC=C1Cl LNKBDFVSILQKSI-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- XGOCKBMEZPNDPJ-UHFFFAOYSA-N 4-bromo-1-chloro-2-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=CC(Br)=CC=C1Cl XGOCKBMEZPNDPJ-UHFFFAOYSA-N 0.000 description 1
- OZFQMHJKAODEON-UHFFFAOYSA-N 4-bromo-1-chloro-2-methylbenzene Chemical compound CC1=CC(Br)=CC=C1Cl OZFQMHJKAODEON-UHFFFAOYSA-N 0.000 description 1
- AJLIJYGWAXPEOK-UHFFFAOYSA-N 4-bromo-1-fluoro-2-(trifluoromethyl)benzene Chemical compound FC1=CC=C(Br)C=C1C(F)(F)F AJLIJYGWAXPEOK-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- CSFDTBRRIBJILD-UHFFFAOYSA-N 4-chloro-2-fluoroaniline Chemical compound NC1=CC=C(Cl)C=C1F CSFDTBRRIBJILD-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- PGFQDLOMDIBAPY-UHFFFAOYSA-N 4-fluoro-3-(trifluoromethyl)aniline Chemical compound NC1=CC=C(F)C(C(F)(F)F)=C1 PGFQDLOMDIBAPY-UHFFFAOYSA-N 0.000 description 1
- NYMDPDNETOLVBS-UHFFFAOYSA-N 4-fluoro-3-methylaniline Chemical compound CC1=CC(N)=CC=C1F NYMDPDNETOLVBS-UHFFFAOYSA-N 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- CHCFQWCZNLRGPV-UHFFFAOYSA-N 5-(3,4-dimethylphenyl)-2-methyl-3-[(2-methylimidazol-1-yl)methyl]pyridine;hydrochloride Chemical compound Cl.CC1=NC=CN1CC1=CC(C=2C=C(C)C(C)=CC=2)=CN=C1C CHCFQWCZNLRGPV-UHFFFAOYSA-N 0.000 description 1
- UGOKZORXHFTPQI-UHFFFAOYSA-N 5-(4-chloro-3-methylphenyl)-1-methyl-2-[(2-methylimidazol-1-yl)methyl]imidazole hydrochloride Chemical compound CC1=C(C=CC(=C1)C2=CN=C(N2C)CN3C=CN=C3C)Cl.Cl UGOKZORXHFTPQI-UHFFFAOYSA-N 0.000 description 1
- TWSTZQHWLXGDIQ-UHFFFAOYSA-N 5-(4-fluoro-3-methylphenyl)-1-methyl-2-[(2-methylimidazol-1-yl)methyl]imidazole hydrochloride Chemical compound CC1=C(C=CC(=C1)C2=CN=C(N2C)CN3C=CN=C3C)F.Cl TWSTZQHWLXGDIQ-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- VVKNIBYWMMCKLV-UHFFFAOYSA-N 5-[4-fluoro-3-(trifluoromethyl)phenyl]-1-methyl-2-[(2-methylimidazol-1-yl)methyl]imidazole hydrochloride Chemical compound CC1=NC=CN1CC2=NC=C(N2C)C3=CC(=C(C=C3)F)C(F)(F)F.Cl VVKNIBYWMMCKLV-UHFFFAOYSA-N 0.000 description 1
- ASPDJZINBYYZRU-UHFFFAOYSA-N 5-amino-2-chlorobenzotrifluoride Chemical compound NC1=CC=C(Cl)C(C(F)(F)F)=C1 ASPDJZINBYYZRU-UHFFFAOYSA-N 0.000 description 1
- MMFGGDVQLQQQRX-UHFFFAOYSA-N 5-bromo-2-fluorobenzaldehyde Chemical compound FC1=CC=C(Br)C=C1C=O MMFGGDVQLQQQRX-UHFFFAOYSA-N 0.000 description 1
- MYQCIMQOENJQSL-UHFFFAOYSA-N 5-chloro-2-[4-[(2-ethylimidazol-1-yl)methyl]imidazol-1-yl]pyridine Chemical compound CCC1=NC=CN1CC1=CN(C=2N=CC(Cl)=CC=2)C=N1 MYQCIMQOENJQSL-UHFFFAOYSA-N 0.000 description 1
- GVDJHERNFPTYSP-UHFFFAOYSA-N 5-chloro-2-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]pyridine Chemical compound CC1=NC=CN1CC1=CN(C=2N=CC(Cl)=CC=2)C=N1 GVDJHERNFPTYSP-UHFFFAOYSA-N 0.000 description 1
- MAXBVGJEFDMHNV-UHFFFAOYSA-N 5-chloropyridin-2-amine Chemical compound NC1=CC=C(Cl)C=N1 MAXBVGJEFDMHNV-UHFFFAOYSA-N 0.000 description 1
- BSLVNOLUEJOXMR-UHFFFAOYSA-N 5-iodo-2,3-dihydro-1-benzofuran Chemical compound IC1=CC=C2OCCC2=C1 BSLVNOLUEJOXMR-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- OESBNEPYXVXJSH-UHFFFAOYSA-N 6-[4-[(2-ethylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CCC1=NC=CN1CC1=CN(C=2C=C3C=CC=NC3=CC=2)C=N1 OESBNEPYXVXJSH-UHFFFAOYSA-N 0.000 description 1
- MQADOHRTNQAZJJ-UHFFFAOYSA-N 6-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CC1=NC=CN1CC1=CN(C=2C=C3C=CC=NC3=CC=2)C=N1 MQADOHRTNQAZJJ-UHFFFAOYSA-N 0.000 description 1
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 1
- UNQYAAAWKOOBFQ-UHFFFAOYSA-N 7-[(4-chlorophenyl)methyl]-8-[4-chloro-3-(trifluoromethoxy)phenoxy]-1-(3-hydroxypropyl)-3-methylpurine-2,6-dione Chemical compound C=1C=C(Cl)C=CC=1CN1C=2C(=O)N(CCCO)C(=O)N(C)C=2N=C1OC1=CC=C(Cl)C(OC(F)(F)F)=C1 UNQYAAAWKOOBFQ-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- BGNAWGKGLRCTHY-UHFFFAOYSA-N 8-[4-[(2-ethylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CCC1=NC=CN1CC1=CN(C=2C3=NC=CC=C3C=CC=2)C=N1 BGNAWGKGLRCTHY-UHFFFAOYSA-N 0.000 description 1
- QXKAUNSSCGNFBH-UHFFFAOYSA-N 8-[4-[(2-methylimidazol-1-yl)methyl]imidazol-1-yl]quinoline Chemical compound CC1=NC=CN1CC1=CN(C=2C3=NC=CC=C3C=CC=2)C=N1 QXKAUNSSCGNFBH-UHFFFAOYSA-N 0.000 description 1
- WREVVZMUNPAPOV-UHFFFAOYSA-N 8-aminoquinoline Chemical compound C1=CN=C2C(N)=CC=CC2=C1 WREVVZMUNPAPOV-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DPYZIDOERCSAHU-UHFFFAOYSA-N CC1=NC=CN1CC1=NC(C=2C=C(C)C(F)=CC=2)=CN1COCC[Si](C)(C)C Chemical compound CC1=NC=CN1CC1=NC(C=2C=C(C)C(F)=CC=2)=CN1COCC[Si](C)(C)C DPYZIDOERCSAHU-UHFFFAOYSA-N 0.000 description 1
- YOJLMQVCGWDGNH-UHFFFAOYSA-N CC1=NC=CN1CC1=NC(C=2C=C(F)C(F)=CC=2)=CN1COCC[Si](C)(C)C Chemical compound CC1=NC=CN1CC1=NC(C=2C=C(F)C(F)=CC=2)=CN1COCC[Si](C)(C)C YOJLMQVCGWDGNH-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- ICGAFSWUHSHNBZ-UHFFFAOYSA-N Cl.BrC1=CC=C(C=C1)N1C=NC(=C1)CN1C(=NC=C1)CC Chemical compound Cl.BrC1=CC=C(C=C1)N1C=NC(=C1)CN1C(=NC=C1)CC ICGAFSWUHSHNBZ-UHFFFAOYSA-N 0.000 description 1
- UROAEAKXOYJETA-UHFFFAOYSA-N Cl.BrC=1C=C(C=C(C1)F)N1C=NC(=C1)CN1C(=NC=C1)CC Chemical compound Cl.BrC=1C=C(C=C(C1)F)N1C=NC(=C1)CN1C(=NC=C1)CC UROAEAKXOYJETA-UHFFFAOYSA-N 0.000 description 1
- DPBHUIJSOZDBRO-UHFFFAOYSA-N Cl.BrC=1C=C(C=CC1F)N1C=NC(=C1)CN1C(=NC=C1)CC Chemical compound Cl.BrC=1C=C(C=CC1F)N1C=NC(=C1)CN1C(=NC=C1)CC DPBHUIJSOZDBRO-UHFFFAOYSA-N 0.000 description 1
- GPWHBOFTTFKKNU-UHFFFAOYSA-N Cl.C(C)(C)(C)C=1C=C(C=CC1)N1C=NC(=C1)CN1C(=NC=C1)CC Chemical compound Cl.C(C)(C)(C)C=1C=C(C=CC1)N1C=NC(=C1)CN1C(=NC=C1)CC GPWHBOFTTFKKNU-UHFFFAOYSA-N 0.000 description 1
- GUDKEFSGWRLRBQ-UHFFFAOYSA-N Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC(=CC=C1)C(C)C Chemical compound Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC(=CC=C1)C(C)C GUDKEFSGWRLRBQ-UHFFFAOYSA-N 0.000 description 1
- FKWDXALILGCHAV-UHFFFAOYSA-N Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC(=CC=C1)CC Chemical compound Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC(=CC=C1)CC FKWDXALILGCHAV-UHFFFAOYSA-N 0.000 description 1
- KHVTZNKALLKGRT-UHFFFAOYSA-N Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC=C(C=C1)[N+](=O)[O-] Chemical compound Cl.C(C)C=1N(C=CN1)CC=1N=CN(C1)C1=CC=C(C=C1)[N+](=O)[O-] KHVTZNKALLKGRT-UHFFFAOYSA-N 0.000 description 1
- PNSQPNPHBJUYQT-UHFFFAOYSA-N Cl.ClC1=CC(=C(C=C1)N1C=NC(=C1)CN1C(=NC=C1)CC)F Chemical compound Cl.ClC1=CC(=C(C=C1)N1C=NC(=C1)CN1C(=NC=C1)CC)F PNSQPNPHBJUYQT-UHFFFAOYSA-N 0.000 description 1
- NJXLISNVJPYCLT-UHFFFAOYSA-N Cl.ClC=1C=C(C=CC1F)N1C=NC(=C1)CN1C(=NC=C1)CC Chemical compound Cl.ClC=1C=C(C=CC1F)N1C=NC(=C1)CN1C(=NC=C1)CC NJXLISNVJPYCLT-UHFFFAOYSA-N 0.000 description 1
- FKLJPTJMIBLJAV-UHFFFAOYSA-N Compound IV Chemical compound O1N=C(C)C=C1CCCCCCCOC1=CC=C(C=2OCCN=2)C=C1 FKLJPTJMIBLJAV-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000023105 Huntington disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- FBMMUXAGOGMREU-UHFFFAOYSA-N O.[Mn+4] Chemical compound O.[Mn+4] FBMMUXAGOGMREU-UHFFFAOYSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- ZECLHFIAYLJFBA-UHFFFAOYSA-N [1-(3,4-dichlorophenyl)imidazol-4-yl]methanamine Chemical compound C1=NC(CN)=CN1C1=CC=C(Cl)C(Cl)=C1 ZECLHFIAYLJFBA-UHFFFAOYSA-N 0.000 description 1
- UWYOFBUMVLFNHS-UHFFFAOYSA-N [1-(4-fluoro-3-methoxyphenyl)imidazol-4-yl]methanol Chemical compound C1=C(F)C(OC)=CC(N2C=C(CO)N=C2)=C1 UWYOFBUMVLFNHS-UHFFFAOYSA-N 0.000 description 1
- JXGNFHRTZJXGTB-UHFFFAOYSA-N [1-[[1-(3,4-dichlorophenyl)imidazol-4-yl]methyl]imidazol-2-yl]methanol Chemical compound OCC1=NC=CN1CC1=CN(C=2C=C(Cl)C(Cl)=CC=2)C=N1 JXGNFHRTZJXGTB-UHFFFAOYSA-N 0.000 description 1
- OLIDNOQZAJTAJJ-UHFFFAOYSA-N [3-(3,4-dichlorophenyl)-5-[[2-(methylamino)imidazol-1-yl]methyl]imidazol-4-yl]methanol;hydrochloride Chemical compound Cl.CNC1=NC=CN1CC1=C(CO)N(C=2C=C(Cl)C(Cl)=CC=2)C=N1 OLIDNOQZAJTAJJ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000002820 allylidene group Chemical group [H]C(=[*])C([H])=C([H])[H] 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- LNAMMBFJMYMQTO-FNEBRGMMSA-N chloroform;(1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 LNAMMBFJMYMQTO-FNEBRGMMSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010549 co-Evaporation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- AUQDITHEDVOTCU-UHFFFAOYSA-N cyclopropyl cyanide Chemical compound N#CC1CC1 AUQDITHEDVOTCU-UHFFFAOYSA-N 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- HQWPLXHWEZZGKY-UHFFFAOYSA-N diethylzinc Chemical compound CC[Zn]CC HQWPLXHWEZZGKY-UHFFFAOYSA-N 0.000 description 1
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- PCPIANOJERKFJI-UHFFFAOYSA-N ethyl 5-bromopyridine-3-carboxylate Chemical compound CCOC(=O)C1=CN=CC(Br)=C1 PCPIANOJERKFJI-UHFFFAOYSA-N 0.000 description 1
- VLDUBDZWWNLZCU-UHFFFAOYSA-N ethyl 5-methyl-1h-imidazole-4-carboxylate Chemical compound CCOC(=O)C=1NC=NC=1C VLDUBDZWWNLZCU-UHFFFAOYSA-N 0.000 description 1
- HIZBBMJRKKKMKY-UHFFFAOYSA-N ethyl cyclopropanecarboximidate Chemical compound CCOC(=N)C1CC1 HIZBBMJRKKKMKY-UHFFFAOYSA-N 0.000 description 1
- SGEMMELRMUVIHJ-UHFFFAOYSA-N ethyl cyclopropanecarboximidate;hydrochloride Chemical compound Cl.CCOC(=N)C1CC1 SGEMMELRMUVIHJ-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PEHSSTUGJUBZBI-UHFFFAOYSA-N indan-5-ol Chemical compound OC1=CC=C2CCCC2=C1 PEHSSTUGJUBZBI-UHFFFAOYSA-N 0.000 description 1
- 125000003454 indenyl group Chemical class C1(C=CC2=CC=CC=C12)* 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- KCCSBYUQLFEETJ-UHFFFAOYSA-N methyl 1h-imidazole-4-carboxylate Chemical compound COC(=O)C1=CN[C]=N1 KCCSBYUQLFEETJ-UHFFFAOYSA-N 0.000 description 1
- JZFLATQBIPILFS-UHFFFAOYSA-N methyl 4-bromopyridine-2-carboxylate Chemical compound COC(=O)C1=CC(Br)=CC=N1 JZFLATQBIPILFS-UHFFFAOYSA-N 0.000 description 1
- AAJZXPWBILCHAW-UHFFFAOYSA-N methyl 5-bromopyridine-3-carboxylate Chemical compound COC(=O)C1=CN=CC(Br)=C1 AAJZXPWBILCHAW-UHFFFAOYSA-N 0.000 description 1
- SRKXRSZSAATCAU-UHFFFAOYSA-N methyl 6-(3,4-dichlorophenyl)pyridine-2-carboxylate Chemical compound COC(=O)C1=CC=CC(C=2C=C(Cl)C(Cl)=CC=2)=N1 SRKXRSZSAATCAU-UHFFFAOYSA-N 0.000 description 1
- SGNCOKUHMXLGAH-UHFFFAOYSA-N methyl 6-bromopyridine-2-carboxylate Chemical compound COC(=O)C1=CC=CC(Br)=N1 SGNCOKUHMXLGAH-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- VFBILHPIHUPBPZ-UHFFFAOYSA-N n-[[2-[4-(difluoromethoxy)-3-propan-2-yloxyphenyl]-1,3-oxazol-4-yl]methyl]-2-ethoxybenzamide Chemical compound CCOC1=CC=CC=C1C(=O)NCC1=COC(C=2C=C(OC(C)C)C(OC(F)F)=CC=2)=N1 VFBILHPIHUPBPZ-UHFFFAOYSA-N 0.000 description 1
- DOWVMJFBDGWVML-UHFFFAOYSA-N n-cyclohexyl-n-methyl-4-(1-oxidopyridin-1-ium-3-yl)imidazole-1-carboxamide Chemical compound C1=NC(C=2C=[N+]([O-])C=CC=2)=CN1C(=O)N(C)C1CCCCC1 DOWVMJFBDGWVML-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- SRTKIHVQZYXHHJ-UHFFFAOYSA-N n-methyl-3-(trifluoromethyl)aniline Chemical compound CNC1=CC=CC(C(F)(F)F)=C1 SRTKIHVQZYXHHJ-UHFFFAOYSA-N 0.000 description 1
- KUVIRDUPAGKTER-UHFFFAOYSA-N n-phenylmethoxyaniline Chemical compound C=1C=CC=CC=1CONC1=CC=CC=C1 KUVIRDUPAGKTER-UHFFFAOYSA-N 0.000 description 1
- KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 230000016273 neuron death Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridine hydrochloride Substances [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- RJSRSRITMWVIQT-UHFFFAOYSA-N quinolin-6-amine Chemical compound N1=CC=CC2=CC(N)=CC=C21 RJSRSRITMWVIQT-UHFFFAOYSA-N 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 238000010129 solution processing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- XPDWGBQVDMORPB-UHFFFAOYSA-N trifluoromethane acid Natural products FC(F)F XPDWGBQVDMORPB-UHFFFAOYSA-N 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01101947.8 | 2001-01-29 | ||
| EP01101947 | 2001-01-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN028042557A Division CN1489580B (zh) | 2001-01-29 | 2002-01-21 | 咪唑衍生物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101798298A CN101798298A (zh) | 2010-08-11 |
| CN101798298B true CN101798298B (zh) | 2013-01-09 |
Family
ID=8176317
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101215002A Expired - Fee Related CN101798298B (zh) | 2001-01-29 | 2002-01-21 | 咪唑衍生物 |
| CN028042557A Expired - Fee Related CN1489580B (zh) | 2001-01-29 | 2002-01-21 | 咪唑衍生物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN028042557A Expired - Fee Related CN1489580B (zh) | 2001-01-29 | 2002-01-21 | 咪唑衍生物 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US6610723B2 (OSRAM) |
| EP (1) | EP1358165B1 (OSRAM) |
| JP (1) | JP4094956B2 (OSRAM) |
| KR (1) | KR100619106B1 (OSRAM) |
| CN (2) | CN101798298B (OSRAM) |
| AR (1) | AR035422A1 (OSRAM) |
| AT (1) | ATE425147T1 (OSRAM) |
| BR (1) | BR0206758A (OSRAM) |
| CA (1) | CA2434813C (OSRAM) |
| CY (1) | CY1110265T1 (OSRAM) |
| DE (1) | DE60231477D1 (OSRAM) |
| DK (1) | DK1358165T3 (OSRAM) |
| ES (1) | ES2319967T3 (OSRAM) |
| GC (1) | GC0000318A (OSRAM) |
| GT (1) | GT200200013A (OSRAM) |
| JO (1) | JO2292B1 (OSRAM) |
| MX (1) | MXPA03006773A (OSRAM) |
| MY (1) | MY138334A (OSRAM) |
| PA (1) | PA8537801A1 (OSRAM) |
| PE (1) | PE20020917A1 (OSRAM) |
| PT (1) | PT1358165E (OSRAM) |
| WO (1) | WO2002060877A1 (OSRAM) |
| ZA (1) | ZA200305626B (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005531548A (ja) * | 2002-05-02 | 2005-10-20 | ニューロジェン コーポレイション | 置換イミダゾール誘導体:gabaa受容体リガンド |
| WO2005028467A1 (en) | 2003-09-15 | 2005-03-31 | Anadys Pharmaceuticals, Inc. | Antibacterial 3,5-diaminopiperidine-substitute aromatic and heteroaromatic compounds |
| JP4836280B2 (ja) | 2004-06-18 | 2011-12-14 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | 癌を治療するためのキネシンスピンドルタンパク質(ksp)阻害剤としてのn−(1−(1−ベンジル−4−フェニル−1h−イミダゾール−2−イル)−2,2−ジメチルプロピル)ベンズアミド誘導体および関連化合物 |
| ITRM20050094A1 (it) * | 2005-03-04 | 2006-09-05 | Univ Siena | Derivati del 1-(1,5-di(4-clorofenil)-2metil-1h-3-pirroli)metil)-4-metilpiperazina (bm 212), procedimento per la loro produzione e uso di essi come antitubercolari. |
| EP1940822A1 (en) | 2005-10-14 | 2008-07-09 | NeuroSearch A/S | Imidazole derivatives and their use for modulating the gaba-a receptor complex |
| KR100694181B1 (ko) * | 2005-11-25 | 2007-03-12 | 연세대학교 산학협력단 | 근원세포 또는 근섬유로부터 신경세포 분화를 유도하는화합물, 이를 포함하는 약학적 조성물, 신경세포 분화를유도하는 방법 및 신경세포 분화를 유도하는 화합물을검색하는 스크리닝 방법 |
| CN101711242B (zh) * | 2007-05-23 | 2013-09-25 | 阿勒根公司 | 作为肾上腺素能受体激动剂的((二环杂芳基)咪唑基)甲基杂芳基化合物 |
| WO2010009327A1 (en) * | 2008-07-17 | 2010-01-21 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| BRPI0916576A2 (pt) | 2008-08-04 | 2017-06-27 | Chdi Inc | pelo menos uma entidade química, composição farmacêutica, e, método para tratar uma condição ou distúrbio. |
| PH12012501480A1 (en) | 2010-01-25 | 2012-10-22 | Chdi Foundation Inc | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| WO2011101457A1 (en) | 2010-02-18 | 2011-08-25 | B.R.A.I.N. Biotechnology Research And Information Network Ag | Chimeric surface active proteins |
| EP2630136A1 (en) * | 2010-10-21 | 2013-08-28 | Universität des Saarlandes | Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases |
| AU2012300246A1 (en) | 2011-08-30 | 2014-03-06 | Chdi Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| EP3243515B1 (en) | 2011-08-30 | 2019-10-16 | CHDI Foundation, Inc. | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| US9199975B2 (en) | 2011-09-30 | 2015-12-01 | Asana Biosciences, Llc | Biaryl imidazole derivatives for regulating CYP17 |
| EP2760854B1 (en) * | 2011-09-30 | 2017-08-30 | Asana BioSciences, LLC | Imidazole derivatives as cyp17 inhibitors for the treatment of cancer |
| US8809372B2 (en) | 2011-09-30 | 2014-08-19 | Asana Biosciences, Llc | Pyridine derivatives |
| AP2017009724A0 (en) | 2014-07-17 | 2017-01-31 | Chdi Foundation Inc | Methods and compositions for treating hiv-related disorders |
| JP6605020B2 (ja) * | 2014-08-15 | 2019-11-13 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | Nr2b受容体阻害剤としてのトリアゾール |
| HUE049278T2 (hu) * | 2014-08-15 | 2020-09-28 | Janssen Pharmaceuticals Inc | Pirazolok |
| DE102015011861B4 (de) | 2015-09-10 | 2018-03-01 | Rudolf Schindler | Neue cyclische Carboxamide als NMDA NR2B Rezeptor Inhibitoren |
| BR112018016329A2 (pt) | 2016-02-10 | 2018-12-18 | Janssen Pharmaceutica Nv | 1,2,3-triazóis substituídos como moduladores de nmda seletivos para nr2b |
| TW201819376A (zh) | 2016-10-06 | 2018-06-01 | 比利時商健生藥品公司 | 經取代之1H-咪唑並[4,5-b]吡啶-2(3H)-酮及其作為GLUN2B受體調節劑之用途 |
| TW201822637A (zh) | 2016-11-07 | 2018-07-01 | 德商拜耳廠股份有限公司 | 用於控制動物害蟲的經取代磺醯胺類 |
| CN112074505B (zh) | 2018-03-08 | 2024-04-05 | 因赛特公司 | 作为PI3K-γ抑制剂的氨基吡嗪二醇化合物 |
| JP7346441B2 (ja) | 2018-04-04 | 2023-09-19 | ヤンセン ファーマシューティカ エヌ.ベー. | 置換ピリジン及びピリミジン並びにglun2b受容体調節物質としてのそれらの使用 |
| US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
| KR20220024403A (ko) | 2019-06-14 | 2022-03-03 | 얀센 파마슈티카 엔.브이. | 치환된 피라졸로-피라진 및 이들의 glun2b 수용체 조절제로서의 용도 |
| JP7667097B2 (ja) | 2019-06-14 | 2025-04-22 | ヤンセン ファーマシューティカ エヌ.ベー. | 置換ピラゾロ-ピリジンアミド及びglun2b受容体調節因子としてのその使用 |
| BR112021025141A2 (pt) | 2019-06-14 | 2022-01-25 | Janssen Pharmaceutica Nv | Pirazolo-piridinas heteroaromáticas substituídas e seu uso como moduladores do receptor glun2b |
| CA3142998A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Pyrazine carbamates and their use as glun2b receptor modulators |
| US11618750B2 (en) | 2019-06-14 | 2023-04-04 | Janssen Pharmaceutica Nv | Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulators |
| CA3143102A1 (en) | 2019-06-14 | 2020-12-17 | Janssen Pharmaceutica Nv | Substituted pyrazolo[4,3-b]pyridines and their use as glun2b receptor modulators |
| MX2021015508A (es) | 2019-06-14 | 2022-01-31 | Janssen Pharmaceutica Nv | Carbamatos de piridina y su uso como moduladores del receptor glun2b. |
| CN115656401B (zh) * | 2022-11-09 | 2025-03-28 | 武汉海特生物创新医药研究有限公司 | 一种咪唑-4-甲酸乙酯纯度的hplc检测方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088925A (zh) * | 1993-01-02 | 1994-07-06 | 山道士有限公司 | 咪唑基甲基吡啶 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3627155A1 (de) | 1986-08-11 | 1988-02-18 | Schering Ag | Imidazol-derivate |
| US5872136A (en) * | 1996-04-03 | 1999-02-16 | Merck & Co., Inc. | Arylheteroaryl inhibitors of farnesyl-protein transferase |
| US5998424A (en) * | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| IT1300055B1 (it) | 1998-04-17 | 2000-04-05 | Boehringer Ingelheim Italia | Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici |
| DK1070708T3 (da) | 1999-07-21 | 2004-05-10 | Hoffmann La Roche | Triazolderivater |
-
2001
- 2001-12-20 US US10/029,342 patent/US6610723B2/en not_active Expired - Lifetime
-
2002
- 2002-01-21 CN CN2010101215002A patent/CN101798298B/zh not_active Expired - Fee Related
- 2002-01-21 CN CN028042557A patent/CN1489580B/zh not_active Expired - Fee Related
- 2002-01-21 PT PT02714095T patent/PT1358165E/pt unknown
- 2002-01-21 DK DK02714095T patent/DK1358165T3/da active
- 2002-01-21 WO PCT/EP2002/000552 patent/WO2002060877A1/en not_active Ceased
- 2002-01-21 MX MXPA03006773A patent/MXPA03006773A/es active IP Right Grant
- 2002-01-21 EP EP02714095A patent/EP1358165B1/en not_active Expired - Lifetime
- 2002-01-21 DE DE60231477T patent/DE60231477D1/de not_active Expired - Lifetime
- 2002-01-21 AT AT02714095T patent/ATE425147T1/de active
- 2002-01-21 ES ES02714095T patent/ES2319967T3/es not_active Expired - Lifetime
- 2002-01-21 KR KR1020037009992A patent/KR100619106B1/ko not_active Expired - Fee Related
- 2002-01-21 CA CA002434813A patent/CA2434813C/en not_active Expired - Fee Related
- 2002-01-21 JP JP2002561027A patent/JP4094956B2/ja not_active Expired - Fee Related
- 2002-01-21 BR BR0206758-7A patent/BR0206758A/pt not_active IP Right Cessation
- 2002-01-24 PA PA20028537801A patent/PA8537801A1/es unknown
- 2002-01-24 PE PE2002000055A patent/PE20020917A1/es not_active Application Discontinuation
- 2002-01-25 MY MYPI20020294A patent/MY138334A/en unknown
- 2002-01-25 AR ARP020100261A patent/AR035422A1/es not_active Application Discontinuation
- 2002-01-28 GC GCP20021833 patent/GC0000318A/en active
- 2002-01-28 GT GT200200013A patent/GT200200013A/es unknown
- 2002-01-29 JO JO20029A patent/JO2292B1/en active
-
2003
- 2003-02-11 US US10/364,596 patent/US6683097B2/en not_active Expired - Lifetime
- 2003-02-13 US US10/365,995 patent/US6667335B2/en not_active Expired - Lifetime
- 2003-07-21 ZA ZA200305626A patent/ZA200305626B/en unknown
-
2009
- 2009-05-15 CY CY20091100522T patent/CY1110265T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1088925A (zh) * | 1993-01-02 | 1994-07-06 | 山道士有限公司 | 咪唑基甲基吡啶 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101798298B (zh) | 咪唑衍生物 | |
| JP3564133B2 (ja) | ▲iv▼型ホスホジェステラーゼ阻害因子としてのキノリン類 | |
| DE69736642T2 (de) | Heterocyclische Verbindungen, ihre Herstellung und Verwendung | |
| EP1194144B1 (en) | Antibacterial compounds | |
| US5332831A (en) | Benzofuran derivatives | |
| US5998437A (en) | Benzimidazole derivatives | |
| CA2129146A1 (en) | Imidazole, triazole and tetrazole derivatives | |
| CN101835752A (zh) | 用于治疗癌症和银屑病的杂环酰胺 | |
| CZ303101B6 (cs) | Prípravek podporující tvorbu/sekreci neurotropinu | |
| CA2643011A1 (en) | Quinolones useful as inducible nitric oxide synthase inhibitors | |
| DE69810760T2 (de) | Verbindungen mit kondensierten ringen, verfahren zu ihrer herstellung und ihre anwendung | |
| US20080214622A1 (en) | Substituted Triazole Derivatives As Oxytocin Antagonists | |
| KR870000548B1 (ko) | 3-카르보닐-1-아미노알킬-1 h-인돌의 제조방법 | |
| US5922718A (en) | Triazolones as apolipoprotein-B synthesis inhibitors | |
| JP2003277379A (ja) | 含窒素複素環化合物、その製造法および用途 | |
| US6248768B1 (en) | Benzimidazole derivatives and pharmacologically acceptable salts thereof | |
| AU2002246043B2 (en) | Imidazole derivatives | |
| HK1146646B (en) | Imidazole derivatives | |
| HK1063794B (en) | Imidazole derivatives | |
| AU2002246043A1 (en) | Imidazole derivatives | |
| TWI328584B (en) | Imidazole derivatives | |
| AU2016366443A1 (en) | Aminoazole derivative | |
| ME01934B (me) | Derivati pirazola kao modulatori protein kinaze | |
| JPWO2001030764A1 (ja) | 1−置換フェニル−1−(1h−イミダゾール−4−イル)アルコール類、その製造法および用途 | |
| TW201307294A (zh) | 雜環化合物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1146646 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1146646 Country of ref document: HK |
|
| ASS | Succession or assignment of patent right |
Owner name: EVOTEC INTERNATIONAL GMBH Free format text: FORMER OWNER: F. HOFFMANN-LA ROCHE AG Effective date: 20130826 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20130826 Address after: hamburg Patentee after: Ethiopia wodtke International Co. Ltd. Address before: Basel Patentee before: F. Hoffmann-La Roche AG |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130109 Termination date: 20170121 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |